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SEC T I ON 
I 
Overview 
ANIMALS ARE U SED extensively in laboratory procedures, especially in biomedical 
research, toxicity testing, and education. Estimates of current usage range from about 
twenty million to seventy million animals per year in the U nited States alone. 1·2 
Many of these animals suffer severely. Some are deliberately sickened, injured, or 
killed. Others suffer from neglect, ignorance, indifference, or outright cruelty. 
No one wants to see animals suffer, regardless of one's opinion of the ethics of 
animal research. For that reason alone, alternative methods should be developed to 
replace the use of animals in laboratory procedures, to reduce animal use, or to 
refine procedures so that pain or suffering is reduced. Replacement, reduction, and 
refinement constitute the three Rs of the "alternatives approach" to laboratory 
practices. The ultimate goal of this approach is the complete replacement of 
laboratory animals with non-animal methods. 
I. Typical housing of monkeys used in research
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The enormous toll in animal suffering is only one reason why the scientific and 
lay communities should make every effort to explore research alternatives. Others are 
the high cost and long duration of animal studies; potential inaccuracies in 
extrapolating from animals to humans; the questionable value of animal-based 
toxicity tests; and limitations on what can be learned from conventional animal 
studies. 3 Scientists are recognizing that alternatives can be more effective and 
practical than animal studies. 
Five major types of alternatives have been developed: 
(1) Human studies include clinical, epidemiological, and postmortem
investigations. For example, most substances known to cause cancer in humans have 
been identified by epidemiological studies, not animal tests. 
(2) In vitro techniques are used to study tissues, cells, or cellular components in
the controlled environment of laboratory containers. Living samples can be taken 
from humans or animals. Even though animals may be used, one animal usually 
provides enough tissue for numerous samples or the tissue can be propagated 
indefinitely, serving study after study. In vitro techniques have been used in research 
on AIDS ( Acquired Immune Deficiency Syndrome) to isolate, identify, and 
concentrate the AIDS virus and are now being used to screen drugs rapidly for 
anti-AIDS virus activity. 
(3) Mathematical models describe a biological system under study in
mathematical terms in order to predict novel features of that system. Existing 
information about the system is used to design the model and make predictions. For 
example, a model has been designed as a potential replacement for the animal-based 
LD50 test, which estimates the dose of a substance needed to kill fifty percent of the 
test animals. The model is designed to predict the lethal dose of untested chemicals 
by comparing them to tested chemicals on the basis of chemical structure and 
properties. Modeling can also identify the most fruitful avenue to pursue in an 
ongoing study and thereby preclude fruitless experimentation. 
(4) Less sentient organisms are used on the premise that some organisms have
less capacity for pain and suffering than do others. In general, invertebrates, 
microorganisms, and plants are less sentient than vertebrates, and vertebrate embryos 
are less sentient than the adults. The A mes test uses bacteria instead of animals to 
detect cancer-causing chemicals. 
(5) Physical/chemical techniques exploit instruments and chemical procedures,
not animals, to analyze the physical and chemical properties of drugs, body 
chemicals, and other compounds. For example, diagnostic kits made of simple 
materials and chemicals have replaced the use of rabbits in diagnosing pregnancy. 
Physical/ chemical techniques can also reduce animal use if they perform their tasks 
better than cruder methods and thereby require fewer animals per test. 
Several other alternative techniques are available. These include (1) mechanical 
models, which can be used in car-crash studies; (2) clinical studies of animals, which 
can have carry-over effects in human medicine; and (3) computer-aided drug design, 
which avoids the animal-based trial-and-error process of drug discovery 
so prominent today. 
Two noteworthy targets for alternative techniques are the LD50 test and the 
Draize test, both of which have been widely criticized on scientific and humane 
grounds. The LD50 test provides an assessment of a compound's poison potential. In 
its most common form, the test involves force-feeding the compound to from 40 to 
200 animals. Several modifications that require fewer than 20 animals have been 
developed and, in some cases, have already been substituted for the traditional test. 
Several promising alternatives do not involve LD50 testing at all; instead, they 
invo!ve tech�iques such as in vitro methods, mathematical modeling, and use of less 
sentient species. 
The Draize test assesses a chemical's potential to damage the eye. Recently 
developed modifications have the potential to refine the test (which now is 
performed on rabbits) by providing anesthetics or to reduce the number of 
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animals used per test fiom 6 to 18 to fewer than 6. Sev�ral substi�ute tests are 
being developed using in vitro techniques and less sentient orgamsms (e.g., 
chicken embryos). . Despite these promising efforts, the traditional_ forms of the �r�1�e an� 1050tests stay in use, partly as a defense by industry agamst product-habihty claims, 
partly the result of regulators' bureaucratic inertia, par�y thro�gh fear ?f c?nsumer 
backlash, and partly because of inconsistencies among mternational guidelmes. 
A lternatives can play a major role in education. Here are a few examples of how 
they can be put to use: . ( 1) The British system for training surgeons C3:fl replace the_ Am�ncan system of
practicing surgery on healthy animals. The former is an appr_enuceship that_ stresses 
clinical experience with humans (for medical students) or animals (for vetermary 
students). In microsurgery, whose fine details make apprenticeship difficult, human 
placentas may soon replace animals in training specialists. . (2) Computer-assisted mannequins that simulate the workings of the human
or animal body can demonstrate medical procedures, normal physiology, and 
drug effects. 
(3) Computer programs can simulate surgical procedures, drug effects, and
metabolic functions. 
( 4) Human cadavers can be used in virtually all aspects of me�ical training.
Progress in developing alterna_tiv�s in all ar�as _of laboratory antmal use has been 
encouraging, especially given the limited financ!al _mvestment that has, so far, _been 
forthcoming. Much of this progress has come withm the last ten years
_, 
as public 
concern for animals has provided greater incentive to develop alternatives_. Such 
public concern can influence laboratory practices and benefit not only ammals, but 
also scientific progress and public health. 
Scientific innovations are making the direct study of humans (as opposed to the 
study of "animal models" of humans) increasingly pract�cal and_ rewardi?g. 
Conventional clinical studies are being supplemented with tn vitro studies of human 
tissues or modeling studies using human data. Sophisticated new imaging 
techniques, which can generate visual images of the body's inte�io� wi�out the need 
for invasive procedures, are being used to study the human brain _m acuon 
harmlessly. In all of this research, the direct study of hu�ans o�viates th� need to 
draw conclusions about humans from potentially misleadmg antmal studies. 
In toxicity testing, recent emphasis on alternative approaches is generat�g a. reevaluation of routine animal tests that, in some cases, are decades old. Testmg is 
being brought out of the Dark Ages. . Unfortunately, despite clear evidence of the importance of alternative methods 
in the history of biomedical research, the scientific community is generally lukew�m 
to the alternatives approach. If the general public became more aw�e of _alternatives
and the promise they hold and communicated that awareness to their legislators 
(who control most of the research funding), the scientific community would _have_ to 
take alternatives more seriously. Our hope is that, through efforts such as this guide,
we can·add to that awareness. 
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II 
A Closer Look 
At Replacements, Reductions, 
And Refmernents 
THE ULTIMATE GOAL of the search for alternatives is the complete replacement of 
animals in all laboratory procedures. While some procedures have been replaced 
completely, replacement in all of biomedical research, testing, and education will 
take many years. Reductions and refinements can be viewed as interim steps toward 
the achievement of complete replacement. The practice of seeking replacements, 
reductions, and refinements to animal experimentation is the "alternatives 
approach." While some animal advocates include only replacements in this approach, 
such a view is unnecessarily restrictive. 
L et us look at the concepts of replacement, reduction, and refinement as they 
can be applied in biomedical research, toxicity testing, and education. 
Replacement 
In biomedical research, an alternative technique known as tissue culture has 
replaced, to a great extent, the use of animals in research on viruses, which cause a 
variety of diseases. Tissue culture involves maintaining samples of living cells or 
tissue from the body in laboratory containers. Studying viruses in tissue culture 
enables researchers to concentrate the virus and to screen drugs for anti-viral activity. 
Tissue-culture research on AIDS has isolated, identified, and concentrated the AIDS 
virus. This technique is now being used to screen drugs quickly for anti-AIDS virus 
activity. The results of some of these tests have been promising. 1 
In toxicity testing, tissue culture may replace the use of animals in detecting 
chemicals that cause photosensitivity reactions in humans. These chemicals cause 
inflammation or tissue damage when ingested or applied to the skin, but only in the 
presence of light. Existing tests for photosensitizing activity, including experiments 
on animals and human volunteers, are inadequate. A recently developed alternative 
uses a certain type of human blood cell. When these cells are incubated with 
photosensitizing chemicals in the presence of light, their genetic activity is slowed. 
The test monitors this activity. The test is quick, inexpensive, and reliable, and 
yields results comparable to those of in vivo tests.2 
In education, computer-assisted mannequins are replacing some uses of animals 
in medical training. A mannequin known as "Sim" is used to train anesthesiologists 
at the U niversity of Southern California Medical Center. Sim responds appropriately 
to various procedures, such as intramuscular injections of certain drugs. Students can 
draw blood, pass a catheter, practice intubation, and administer treatment for shock. 
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II. Sim, a computen'zed mannequin that can replace animals
as subjects on which to practice medical procedures
In tests comparing students who practiced on the first prototype (Sim One) to a 
group who trained on animals, the Sim One students consistently needed fewer tries 
and less time to master intubation techniques. A new version of the mannequin is 
now being mass-produced. 
Reduction 
Reduction alternatives are based on the premise that the number of animals 
used in a procedure should be the minimum necessary to achieve the desired goal. 
This premise can be applied to the design of experiments, as certain designs are 
more economical in their use of animals than are others. 3 Once a design has been 
chosen, one needs to determine judiciously the number of animals to be used 
in experimental and control groups. This planning can be aided by certain 
statistical methods. 
In biomedical research, the potential for reduction in the number of animals 
used was illustrated in an unpublished analysis commissioned by The Humane 
Society of the United States. In a random sample of published research reports, in 
nearly all cases, animal use could have been reduced from twenty-five percent to 
more than seventy percent simply by a better choice of experimental design and 
statistical tests. The quality of the results or their statistical validity would not have 
been compromised. 
In toxicity testing, the principle of reduction has been applied to the LD50 test, 
used to estimate the lethal dose of a substance. This test traditionally involves from 
40 to 200 animals. A modification of this test uses 6 to 10 animals to determine the 
approximate lethal dose (ALD). In the ALD test, each animal is given a dose fifty 
percent higher than the one given to the previous animal. This procedure continues 
until a lethal (or fatal) dose is reached. The ALD test produces results that correlate 
well with the traditional L D50, yet it uses far fewer animals.4 
In education, the number of animals used in high school and college dissections 
can easily be reduced. Instead of each student dissecting a different animal, students 
can view a few professionally dissected animals. These prepared specimens, known as 
prosections, illustrate anatomy with a clarity that few student-prepared specimens 
can match. Specially preserved and encased prosections can be used year after year, 
sparing additional animal sacrifice. 
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Refinement 
Any modification in the care and use of laboratory animals is a refinement if it 
reduces pain and suffering without compromising the outcome of the intended 
laboratory project. Refinements can be beneficial from a scientific as well as humane 
view because pain and suffering lead to behavioral, physiolofical, and anatomical 
abnormalities that can distort the outcome of experiments. 5• 
Refinements can yield the most immediate changes in the area of alternatives. 
Living quarters can be made more comfortable, diet improved, and anesthetics and 
analgesics administered more widely. The application of refinements is limited 
largely by the imagination and motivation of experimenters and their technicians. 
In biomedical research, some procedures used for the long-term restraint of 
animals are being refined. Traditionally, scientists have immobilized animals for 
weeks or months at a time to prevent them from pulling tubes from their bodies, to 
facilitate the administration of frequently injected drugs, or for a variety of other 
reasons. Restraining devices such as primate restraint chairs are being replaced by
various systems that allow freedom of movement, such as harnesses, tethers, and 
biotelemetry systems (devices worn externally or implanted internally that transmit 
information from the animal to a remote sensing device). 
Several refinements have been proposed for toxicity tests. In Draize testing, 
chemicals are instilled in the eyes of rabbits to assess their irritancy potential. 
Administering anesthetics and analgesics to relieve pain and antihistamines to reduce 
the degree of eye damage would provide some relief to test animals. There has been 
concern that these substances could distort test results or even be counterproductive 
if anesthetics increased injury by inhibiting defensive responses such as blinking7 or if 
antihistamines prolonged recovery from injury. 8 However, some anesthetics do not 
have these drawbacks. 9 
In education, the concept of refinement can be readily applied to laboratory 
exercises in rat behavior that are common in introductory psychology and behavioral 
biology courses. Some of these exercises demonstrate learning principles; some are 
opportunities for students to categorize and observe behavior; and others provide 
opportunities to practice using event recorders ( devices that facilitate the recording of 
behavioral information). Several procedures commonly associated with these exercises 
are needlessly stressful. 
For example, rats are highly social animals yet traditionally have been housed 
singly. They are punished in order to aid learning, when the use of reward would 
accomplish the same goal. They are deprived of food or water in order to enhance 
the performance of some tasks. They are nocturnal animals accustomed to an 
alternating day/ night cycle, yet are often kept in perpetual daylight. If they are 
provided with a day/ night light cycle, they are forced to perform during the 
daytime, when they would normally be inactive. 
Refinements of these procedures are obvious. The animals should be housed 
socially and kept in an environment with an alternating day/night cycle. The cycle 
can be reversed so that the animals are active during the day, when classes are 
usually held. Ideally, the animals should be observed under red light, which 
facilitates student observations but does not distort nighttime activity. The rats 
should be coaxed to learn by reward, not punishment, and their performance 
enhanced through reward with favorite foods, not starvation. 
Although the concepts of replacement, reduction, and refinement are distinct, 
they can be combined in the same alternative procedure. An example is the Limulus 
Amebocyte Lysate (LAL) test, used to determine whether or not therapeutic solutions 
will cause fever when administered intravenously to humans. The fever-producing 
substance, or "pyrogen," is a toxic segment of the contaminating bacteria's surface. 
The active ingredient in the L AL test is obtained from the blood of horseshoe crabs 
that are caught in oceans, handled, and then released. Certain collected red blood 
cells are burst to obtain a clear solution. This solution forms an easily recognized 
opaque gel when mixed with a pyrogenic fluid. 
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The LAL test was recently approved for use by the federal government and is
beginning to replace the older Pyrogen test. The latter uses a minimum of three 
rabbits per test, each of which is administered experimental fluids that can be so 
damaging that the animals have to be killed after the test. The LAL test is over 100 
times more sensitive than the Pyrogen test and is also more economical, convenient, 
and reliable. 10 
The LAL test is a replacement for the Pyrogen test in that laboratory animals are 
not required. The LA L-test involves a reduction in that one horseshoe crab 
substitutes for several rabbits. It is a refinement in that the horseshoe crabs are only 
temporarily disturbed in the wild, while the rabbits live in small cages and are 
subjected to experimental procedures. The LAL test would be a refinement even if 
horseshoe crabs were subjected to the same treatment as rabbits, because horseshoe 
crabs, by virtue of a more primitive nervous system, probably are much less capable 
of experiencing pain than are rabbits. 
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III 
Promotion of the 
Alternatives Concept: History 
THE EARLIER DEFINITIONS of replacement, reduction, and refinement are slight 
modifications of original definitions proposed by W.M.S. Russell and R.L. Burch 
in 1959. 1 Russell and Burch labeled these principles the three Rs of humane 
experimental technique. They also introduced the notions of fidelity and 
discrimination, which are important in assessing the relative merits of using animals 
and alternatives. In the context of biomedical research and testing, animals and 
alternatives are used as surrogates or models for humans. A surrogate is a high 
fidelity model to the extent that it resembles humans. In general, chimpanzees are 
high fidelity models; bacteria are low fidelity models. 
Models can have low fidelity but nevertheless be more useful than high fidelity 
models in certain cases. This is because low fidelity models can be better 
discriminators of the response under study. For example, horseshoe crabs in the LAL 
test are replacing rabbits in the Pyrogen test. Horseshoe crabs happen to be better 
than rabbits in discriminating the human fever response, despite the fact that 
horseshoe crabs are lower fidelity models of humans. 
A failure to consider a model's discrimination or sensitivity can lead to what 
Russell and Burch labeled the "high fidelity fallacy." This fallacy ignores 
discrimination by stating that, in general, models should have high fidelity. In 
practice, this fallacy leads to excessive use of mammals, given their relatively high 
fidelity to humans. This usage pattern can be seen in federally funded research 
projects, discussed later. The high fidelity fallacy must be successfully repudiated 
before alternatives will gain widespread acceptance. 
Since publication of Russell and Burch's book in 1959, several developments in 
the promotion of the alternatives concept have occurred. A nimal protectionists have 
established several organizations to finance the development of alternatives (Table I). 
Perhaps the most prominent of these has been FRAME, which recently began a 
coordinated effort to develop an alternative to the LD50 test. Other organizations are 
promoting alternatives by offering cash prizes. 
Since the 1970s, scientific conferences have been addressing the alternatives 
concept, with mixed results.2 In Canada, a gathering of toxicologists recommended 
that the government and organizations supporting toxicological research "initiate and 
fund research programs with the specific objective of developing and validating 
non-animal models for use in the safety-evaluation process."3 
G overnment action on alternatives began in Europe. In 1971, the Council of 
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TABLE I 
Some Sources of Financial Support for the Development of Alternatives 
A. Organizations established to finance development of alternatives:
Organization 
American Fund for Alternatives 
to Animals in Research 
Location 
United States 
Dr. Hadwen Trust for Humane Research United Kingdom 
FRAME (Fund for the Replacement United Kingdom 
of Animals in Medical Experiments) 
Humane Research Trust 
Irish Anti-Vivisection Society 
Humane Research Fund 
Lawson Tait Trust 





B. Organizations offering monetary awards for alternatives development:
Organization 
Doerenkamp & Zbinden Foundation 
for Realistic Animal Protection in 
Scientific Research 
European Federation of 
Pharmaceutical Industries Associations 
Millenium G uild 
World Society for the Protection 
of Animals (Marchiz Animal 
Welfare Award) 
Area of Award 
Education 
Research or Testing 
Testing 
Research, Testing, or Education 
Europe called for the establishment of a documentation and information center for 
alternatives and a facility to store tissue material to use in alternatives research. 
Unfortunately, progress on this initiative has been slow.4 However, Holland, Sweden, 
and West G ermany have animal-research laws that favorably mention alternatives. 
Sweden has even earmarked a small amount of money for alternatives research.> 
Centers for alternatives research now exist in Switzerland, West G ermany, Canada, 
and the United States. The centers are funded by industry, animal-protection 
groups, and/or governments. 
In the United States, several legislative initiatives on alternatives have been 
advanced since 1980. The one that would have been the most far-reaching, if it had 
passed, is the Research Modernization Act. Introduced in Congress in 1980, it would 
have established a national center for alternatives research, redirected a certain 
percentage of funds originally earmarked for live animal research into alternatives 
research, and coordinated training programs in alternative methods. 
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A legislative breakthrough came in 1985 with passage of the National Institutes 
of Health (NIH) reauthorization bill, which contains provisions on alternatives. 
Sponsored by Representative Doug Walgren, these provisions call for NIH to 
establish a plan for research into replacements, reductions, and refinements. The 
plan must also include the development of such methods that have been found to be 
valid and reliable and the training of scientists in their use. 
Similar provisions are contained in amendments to the Animal Welfare Act that 
became law in December of 1985.6 The amendments were designated the "Improved 
Standards for Laboratory Animals Act" and formerly constituted the Dole/Brown 
bill, named for its sponsors, Senator Robert Dole and Representative G eorge E. 
Brown, Jr. The amendments mandate training for researchers and technicians in 
alternative methods for research and testing. The amendments also call for the 
creation of an information service at the National Agricultural Library in cooperation 
with the National Library of Medicine. The service would provide information on 
alternative research methods, including refinements such as the increased use of 
anesthetics and analgesics, and methods to prevent unintended duplication of 
animal experiments. 
Alternatives in toxicity testing have been promoted by public campaigns against 
the use of animals in the Draize test and the LD50 test. These campaigns are 
spearheaded by large coalitions of animal-protection groups. 
The Draize test is used extensively by the cosmetics industry. The anti-Draize 
campaign singled out a major cosmetic company, Revlon, which, under pressure, 
donated $750,000 in 1980 to Rockefeller University to develop an alternative to the 
Draize test. The rest of the cosmetics industry, also under pressure, contributed one 
million dollars in 1981 to establish the Center for Alternatives to Animal Testing at 
the Johns Hopkins University School of Public Health. The industry, through its 
representative, the Cosmetic, Toiletry, and Fragrance Association, continues to 
support the center and similar efforts at eight other institutions. 
The target of the other campaign, the LD50 test, provides a rough estimate of 
the toxicity of household products and other chemicals. Several federal agencies, 
including the Food and Drug Administration, the Consumer Product Safety 
Commission, and the Environmental Protection Agency, recently announced that 
they no longer require the test for regulatory purposes. These agencies, however, 
continue to accept LD50 results, and industry has been slow to discontinue the test 
in the absence of an outright ban. A bill introduced in the 1985 Congress would 
have required each federal agency actively to discourage use of the LD50 and to 
recommend alternatives. (The bill may be reconsidered in the future.) 
Other noteworthy events in the history of the alternatives approach were the 
recent establishment of a fund for alternatives to animal use in research and teaching 
at Texas A & M's College of Veterinary Medicine and the establishment of the 
United States' first professorship in humane ethics and animal welfare in 1985 at the 
University of Pennsylvania School of Veterinary Medicine. One of the goals of the 
position will be to investigate alternatives to animal experimentation in 
medical research. 7 
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IV 
Current Uses of Animals in 
Education,  Toxicity Testing, 
And Biomedical Research 
THE ALTERNATIVES APPROACH is a response to the use of animals in laboratory 
procedures. Consequently, any thorough analysis of alternatives should discuss the 
nature and scope of laboratory animal use. How many and what types of animals are 
used and for what purposes? Unfortunately, such information is scanty and 
conflicting. Even estimates of total laboratory animal use differ widely. Our 
ignorance on these matters is a reflection of how complacent policymakers are toward 
the use of animals in laboratories. 
Andrew Rowan of the Tufts University School of Veterinary Medicine has 
discussed the shortcomings of existing estimates of laboratory animal use and derived 
his own estimate from a variety of sources. 1 His figures are adopted here. He 
estimated that seventy million animals are used per year in the United States alone.* 
Nearly ninety percent are mice, rats, and other rodents, and the remainder, in 
decreasing numerical importance, are birds, frogs, rabbits, dogs, ungulates, cats, and 
primates. Excluded from these figures are invertebrate animals (e.g., fruit flies, 
squid, and earthworms) because good estimates of numbers are lacking. 
These millions of animals are used in three general activities: education, toxicity 
testing, and biomedical research. 
Education 
Animals are used in a variety of procedures in biological, medical, and 
veterinary education. Such procedures include destroying a frog's brain to test spinal 
reflexes (performed in high school); dissecting cats, dogs, minks, and fish to learn 
anatomy (performed in college); and practicing surgery on dogs obtained from 
pounds (performed in medical and veterinary schools). Some high school students 
*Rowan recent! y subdivided his estimate of animal use to reflect the fact that not all of the animals that 
are bred for research or acquired by laboratories are actually used.2 A certain percentage of these animals 
die or are killed because they do not meet research specifications (e.g., age, sex, weight, general health) .
Estimates of this figure range from a few percent of those acquired to almost fifty percent.l Rowan's 
estimate of the number of animals actually used is twenty-five to thirty-five million animals per year. His 
earlier estimate is retained here because it better reflects the toll that laboratory practices take on animals, 
regardless of whether the animals are actually used. 
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experiment on animals and display their results at science fairs . (For a comprehensive 
discussion of the use of animals in high school biology classes and science fairs , see 
Heather McGiffin and Nancy Brownley's Animals in Education.4)
In the United States, an estimated 5 .  7 million animals are used every year in 
education.) A detailed breakdown of this figure is unavailable, owing primarily to 
the fact that educational and research uses of animals are often intermixed at the 
undergraduate and graduate levels . 
Figures are available for medical and veterinary schools. In the nation's 127 
medical schools, a total of 36,700 animals is used annually, with rats and dogs 
making up seventy-one percent of this total (Table II).6 The majority of these
animals are used in the teaching of surgery (fifty-one percent) and physiology 
(sixteen percent). Most of the dogs (sixty-four percent) are used in these 
two disciplines. 
TABLE II 
Estimated Animal Use in Medical Education in the United States, 1983-84• 
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•Estimate is based on an extrapolation of a survey of sixteen selected medical schools evenly distributed by 
geographic region (Northeast, Midwest , South, or West), ownership (public or private), and research 
expenditures (low, medium, or high) .
binciudes frogs, sheep, and pigeon�. 
SOURCE: Office of Technology Assessment , Alternatives to Animal Use in Research, Testing, and 
Education (Washington, D.C.: OTA, 1986). 
Most of the surveyed medical schools expressed regret over not being able to use 
animals to a greater extent in education , often citing cost as a limiting factor. 
Table III shows comparable data on the nation's veterinary schools.7 The census 
includes only those animals that began an exercise alive and either died or were 
killed during the course of the exercise. The census excludes animals purcksed as 
cadavers (presumably because the carcasses were by-products of other industries); 
those that were clinical patients; and those killed at the schools prior to laboratory 
exercises. The latter exclusion is regrettable because, as a result, the numbers in 
Table III underestimate the adverse impact of veterinary schools on live animals. 
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Estimated Animal Use in Veterinary Education in the United States, 1983-84• 
Kind of Animal Number Used % 
Dog 8,020 48.2 
Mouse 2 , 180 1 3 . 1  
Rat 2,083 12 . 5  
Bird 1 , 323 7.9 
Reptile 433 2.6 
Sheep 423 2 .5  
Cat 414 2.5 
Horse 378 2 .3  
Rabbit 195 1 . 2  
Goat 194 1 .2  
Pig 140 0.8 
Guinea pig 112 0.7 
Cow 1 1 1  0 . 7  
Otherb 649 3 . 5  
TOTAL 16,655 100.1 
•This census of all U.S. veterinary schools does not include privately owned or pet animals used for clinical 
demonstrations, animals purchased as cadavers, or those subjected to euthanas_ia prior to the laborat?ryexercise. It includes only those animals that began the course alive and then either died or were subiected 
to euthanasia during the course of the laboratory session. 
bJncludes fish, frogs, hamsters, and exotic species. 
SOURCE: Office of Technology Assessment, Alternatives. 
In the academic year 1983-84, 16,655 animals were used in veterinary 
education. Dogs account for almost half, and mice, rats , and birds constitute most of 
the remaining animals. . . . 
Education provides fertile ground for the application of alternatives beca�se 
many educational projects are repetitive exercises whose outcomes are know? m 
advance. They are unrefined in that the students who conduct them have little 
knowledge of surgery, anesthesia, experimental design, or the animals' ?eeds. 
Educational uses of animals seem especially ripe for replacements that snnulate 
exercises with the use of films, videotapes, computers, or mannequins. 
Toxicity Testing . . 
Toxicity tests are attempts to determme whether chemicals are safe for human 
use and the limits under which hazardous chemicals can be used safely. Tests are 
conducted on a variety of chemical and biological substance�, . including_ drugs,.vaccines, food additives, cosmetics , household cleaners , pestm_des, and md_ustnalchemicals. Test substances may be force-fed, inhaled, or apphe1 to the skin or eyes. 
Routine testing of new drugs examines the general effects of a smgle d�se (ac1;1te 
toxicity) or repeated doses (chronic toxicity), or sp�c�c effects, such _as mductton ofcancer (carcinogenicity), genetic damage (mutagen1c1ty), and congen1tal 
malformations ( teratogenicity ). 
25 
·C U R RE N T U SE S·
Toxicity testing is an enormous enterprise in the U nited States. It involves an 
esti_mated fourteen million animals per year. 8 The cost of testing a single substance 
varies from about twenty thousand dollars (using a limited range of tests) to over one 
million dollars for a comprehensive evaluation.9 
. In the U nited States, the feder� government plays a major role in toxicity testt�g, both thro1:1gh laws that require or encourage testing and through guidelines 
that mfluence tesung procedures. 10 The Food and Drug Administration (FDA) 
over�e�s mos� tes�i�g. (?ther federal agencies that require animal testing, either 
explmtly or tmplmtly, mclude the Consumer Product Safety Commission, the 
Department of Transponation, and the Environmental Protection Agency. 11 
Product testing is sometimes required for pre-market approval; more often, it is 
simply implied by requirements for safe and effective products. Federal statutes 
explicitly require animal testing in only a handful of instances, such as the Federal 
Hazardous Substances Act (administered by the Consumer Product Safety 
Commission) and the Hazardous Materials Transportation Act (administered by the 
Department of Transportation). 12 
The status quo of toxicity testing is woefully inadequate. Animal tests are too 
costly and time-consuming to protect the public adequately from hazardous 
substances. A basic toxicity study may cost half a million dollars and take two years 
to conduct. Consequently, only a few of the tens of thousands of commercially 
important chemicals have been extensively tested and most have scarcely been tested 
at all. u Furthermore, an estimated one thousand new chemicals enter the market 
every year. 14 There simply are not enough skilled personnel to evaluate the flood of 
new chemicals and the backlog of old chemicals, even if money were available. 1) 
Not only are the duration and cost of animal testing prompting public health 
officials and toxicologists to consider alternatives, but so is the dubious value of 
many animal tests. For example, physicians have severely criticized animal tests for 
birth defects ("teratogenicity tests"). Their criticisms have been compiled by Dr. 
Robert Sharpe of the Lord Dowding Fund for Humane Research. 16• 17 In the book 
Drugs a_nd Pregnancy, physician P. Lewis of Hammersmith Hospital, London, wrote 
that �ntmal teratogenicity tests are "virtually useless scientifically." Another 
contrtbutor to the same book, physician D. Hawkins of the Institute of Obstetrics 
and G ynaecology wrote: "The great majority of perinatal toxicological studies seem to 
be intended to convey medicolegal protection to the pharmaceutical houses and 
political protection to the official regulatory bodies, rather than produce information 
that might be of value in human therapeutics." Physician R. Smithells of the 
U niversity of Leeds characterized the extensive battery of animal teratogenicity tests 
as "more in the nature of a public relations exercise than a serious contribution to 
drug safety." Physician R. Brent of Jefferson Medical College has made 
similar comments. 
Dr. Smith ells also feared that animal teratogenicity tests might do more harm 
than good by screening out new drugs that induced malformations in newborn 
!aboratory animals but could prove therapeutically useful and non-teratogenic
m humans. 
The illogicality of the situation is demonstrated by the continued use of 
well-established drugs which are known to be teratogenic in some 
mammalian species (e.g. aspirin, penicillin/streptomycin, cortisone). 
Conversely, a new drug which comes through its animal reproductive 
studies with flying colours may nevertheless be teratogenic in man. 
The situation is not much better in other areas of toxicity testing. According to 
the International Agency for Research on Cancer: 
. . . At the present time, a correlation between carcinogenicity in animals 
and possible human risk cannot be made on a scientific basis . . . .  No 
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objective criteria exist to interpret animal data directly in terms of 
human risk. 18 
Despite the obvious need for alternatives to animal testing, their promotion is 
not without impediments. National and international regulations that mandate 
animal testing are often inflexible and slow to change. Even when regulations are 
updated in one country, a company seeking to market its products internationally 
may still conduct the same set of traditional animal tests in order to satisfy all 
regulations simultaneously. Companies may also persist in conducting animal tests if 
they view the tests as indispensable in defending themselves from product-liability 
lawsuits. Also, animal testing tends to intensify in response to public outcry against 
newly discovered instances of harmful drugs, hygenic products, and environmental 
chemicals. The time has surely come to reevaluate current toxicity tests, rather than 
intensify their usage. 
Biomedical Research 
Animals are used in biomedical research as "models" or surrogates of human 
beings in order to understand the functioning of the healthy body; determine the 
effects of diseases and trauma on the body; and discover remedies for disorders, 
among other uses. Roughly fifty million animals per year are used in biomedical 
research in the U nited States alone. 19 The degree of their pain and suffering depends 
on the details of their care and use. Many laboratory animals are housed alone in 
small, barren cages. They are pan of a variety of experiments; perhaps the least 
fortunate are those that are burned, frozen, poisoned, blinded, irradiated, crushed, 
infected, or shot. Although anesthetics and analgesics are sometimes administered to 
these animals, they do not provide total relief, as any dental patient knows. 
Animal research is extensive and diverse enough to permit the fruitful 
application of alternatives, especially reduction and refinement. The rapidity and 
extent of this application will depend on financial backing and the imagination and 
motivation of researchers, as well as their perceptions of outside pressure. Certain 
impediments will have to be overcome, however. These include resistance to change 
from the research community and from industries with a financial stake in continued 
animal research, including suppliers of animals, cages, food, and antibiotics. Similar 
considerations apply to the use of animals in education and toxicity testing. 
III. This beagle was burned over a large portion of its body as part of 
an experiment .
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V 
What Are the 
Alternatives? 
THE SAME TYPES of alternatives can be used in both research and toxicity testing. 
These alternatives are in various stages of development and span a wide variety of 
procedures and systems, including human studies, in vitro techniques, mathematical 
and computer modeling, use of less sentient organisms, and physical and chemical 
techniques. We will look at each of these possibilities, then determine how they 
apply to the Draize and LD50 tests. 
Human Studies 
Humans are already used extensively in research. For example, 400,000 to 
800,000 patients a year are enrolled in organized clinical investigations of drugs and 
other treatments in the U.S. 1 However, an even greater emphasis on human studies 
could reduce the demand for laboratory animals. Sick or injured persons could be 
studied to improve the diagnosis, treatment, and prevention of medical problems. 
Healthy volunteers could be incorporated into these clinical studies as controls. 
Healthy volunteers could also be useful in studies that focus on maintaining or 
improving health, rather than on coping with medical problems. 
A second way to conduct human research is to analyze information on large 
numbers of people to uncover potential relationships between the incidence of 
disease or injury and people's habits or environments, such as smoking, drinking, 
and working in certain occupations. These epidemiological studies are helpful in 
identifying probable causes of health problems. Similar studies are helpful in 
identifying promoters of good health. These studies may not convincingly 
demonstrate a cause-and-effect relationship in some cases; however, they are often 
helpful in providing clues that focus future research efforts. 
The remaining category of human research consists of postmortem studies of 
cadavers donated to science. These studies are particularly useful in anatomical and 
transplant research. Cadavers are also sources of transplantable organs. 
Cadavers have far more potential in biomedical research than current usage 
suggests. In fact, postmortem studies could revolutionize research, toxicity testing, 
and education and thereby greatly reduce our reliance on laboratory animals. The 
key, according to a physician2 and an educator and physician,3 is to use cadavers that 
are brain-dead but whose physiological functions are sustained by artificial support 
systems. Known as "neomorts," these cadavers resemble comatose patients but have 
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been certified as legally dead. 
Support systems are even now being used by the biomedical community to keep 
cadavers functional for medical or scientific reasons. A recent example is that of an 
Indiana woman who died as a result of a car accident but whose body was sustained 
by artificial supports until her child could be born by cesarean section several weeks 
later. Although practical problems currently make neomort technology too expensive 
and complicated for widespread use, it is believed that these problems may be solved 
in the near future. 4 Not so likely to be resolved readily, however, are the ethical and 
moral considerations restraining such use . 
Because the availability of neomorts will undoubtedly be limited, priorities for 
their use will have to be established. Likewise, a variety of technical, ethical, and 
legal issues will need to be resolved.5 •6 Scientists believe that such a resolution will 
usher in a new era in biomedicine and science. 
A lthough the reported use �f neomorts has been limited for reasons indicated 
above, an example of one study, as well as examples of more traditional human 
research, is discussed below. 
• Human research has played an important role in the development of artificial
heart implants. The first clinical implant of the so-called Jarvik-7 artificial heart was 
performed in 1982 on Barney Clark. One of the researchers involved in this 
operation remarked that more was learned from this single case than from all of their 
preceding research, which included dozens of implants in animals. Even if this 
remark is an exaggeration, it underscores the importance that researchers attach to 
clinical trials. 
Beyond its role in clinical testing of the Jarvik-7 heart, human research also 
played an important but undervalued role in pre-clinical testing. While it is widely 
known that the Jarvik-7 was extensively tested in animals, it is hardly known (much 
less appreciated) that postmortem studies were also involved. Physicians at Temple 
University implanted the Jarvik-7 heart in five brain-dead humans. They 
experimented with three different surgical implant techniques. They wrote: 
. . .  We were confronted with the question of whether or not an artificial 
heart successfully tested in calves would fit and function in man. But how 
to proceed in man with some assurance of success? . . .  Today it is possible to 
test the functional capabilities of intrathoraic blood pumps in brain-dead 
but hemodynamically stable human subjects at no risk, so that it is not 
necessary to learn the fundamentals of fit and function in patients . . . .  The 
relatives of the deceased subjects have been extremely supportive of our 
experiments. Their hope is that, through these studies, others may live 
longer and more comfortably. 7 
Although this neomort study was a follow-up of animal studies, the clear 
implication of neomort research is that our reliance on laboratory animals will 
be reduced. 
• Recent progress in understanding Alzheimer's disease, or senile dementia,
stems from clinical and postmortem studies of Alzheimer's patients. A natomical and 
biochemical studies were conducted on brains of deceased patients, small brain 
biopsies, and cerebrospinal fluid from living patients. 
• Most substances known to cause cancer in humans have been identified by
epidemiological studies rather than by carcinogen tests in animals.8 These hazards 
were identified primarily through occupational association. 
• Treatments for drug overdose are being improved through clinical studies
conducted at hospital poison centers.9 These centers are designed so that patients can 
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be studied while given emergency treatment. One such center was established at 
G uy's Hospital in England, where researchers concluded :  
Whilst the data from the animai studies required by regulatory bodies 
provide some basic information of the mechanism of toxicity and relative 
toxicity, it cannot be assumed that this information will be entirely relevant 
for man. Furthermore, whilst these studies may give indications as to the 
appropriate treatment for acute overdosage, they are unlikely to indicate 
the efficacy of treatment. &penence gained from a careful assessment of 
patients suffering from acute overdosage of drugs is potentially much more 
useful than that obtained from animal tests. 10 
• Epidemiological studies have linked genetic damage to a variety of factors,
including drugs, metals, industrial chemicals, radiation, tobacco smoke, and alcohol. 
The evidence is particularly strong for vinyl chloride, alcohol, and tobacco - the 
higher the dose, the greater the incidence of genetic damage. 1 1 G enetic damage was 
assessed by monitoring chromosome breakage in certain blood cells. 
Further evidence of the importance of human studies comes from an analysis of 
Nobel Prizes awarded in medicine or physiology. These prestigious prizes are 
awarded for outstanding contributions in basic and applied research. Seventy-two 
prizes have been awarded from 1901 (the year the prizes were initiated) through 
1985. Of these, twenty-two (thirty-one percent) involved human studies to some 
degree, including ten (fourteen percent) projects that were wholly or primarily 
conducted on humans. 
Despite such accomplishments, not all human studies can be considered 
alternatives to animal studies. Instead, many human studies are follow-ups of 
research on animals. Researchers often turn to animals before conducting studies on 
humans because of ethical and practical problems of studying humans directly. 
However, findings from animal studies must be verified in humans because they 
cannot be extrapolated to humans with great accuracy. G iven the uncertainties of 
this extrapolation, follow-up research on humans can truly be regarded as 
experimental and the human subjects regarded as the last in a series of 
"guinea pigs." 
Sophisticated new techniques are helping to overcome ethical and l?racti�al 
restrictions that have limited the extent to which humans could be studied duectly, 
without recourse to potentially misleading animal models. For example, remarkable 
new "imaging" techniques, which can generate visual images of the body's interior 
without the need for invasive procedures, are now being used to harmlessly study the 
human brain in action. One such technique is positron emission tomography (PET): 
tiny amounts of radioactive chemicals mark areas of interest in the brain, and a ��ain 
scanner detects these chemicals and generates pictures or "scans" that show the hvmg 
brain in action. 
PET has recently been applied in the study of Parkinson's disease, which afflicts 
400,000 Americans, mostly the elderly. Sufferers exhibit tremor, muscle rigidity and 
weakness, and a shuffling gait. PET scans were taken of the brains of volunteers who 
were known to have used a synthetic form of heroin tainted with a brain-damaging 
substance. The scans revealed Parkinson's-like damage to specific brain cells in the 
absence of overt signs of the disease. Such signs have begun to appear in persons 
who first used the heroin two years previously. These studies suggested that exposure 
to similar toxic substances may predispose people to develop Parkinson's later in life, 
when additional brain-cell loss occurs as a result of aging. 
This application of PET scans to humans has sparked a revolution in the 
understanding of Parkinson's, which has baffled physicians for_ more _than a century.
12 
Such studies are pointing the way to human research on the d1agnos1s, treatment, 
. 
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In Vitro Techniques 
There is virtually no field of biomedical research that has not been affected 
by in vitro technology. 1� 
Some human and animal tissues can be removed from the body and studied in 
vitro (literally, "in glass," i.e., in a laboratory container). In vitro alternatives can be 
either replacements or reductions. If tissue samples are derived entirely from humans 
(from biopsies, autopsies, and placentas), then the research is a replacement. If 
animals are deliberately killed to obtain tissue samples, then the research is a 
reduction because tissue from a single animal often is enough to substitute for 
several animals. In vitro studies involving animal tissue can be replacements if the 
tissue is propagated indefinitely, providing material for study after study. 
IV. An example of a potential in vitro alternative to the Draize test: 
it assesses the potential of chemicals to inhibit cell growth, which, for 
at least one class of chemicals, correlates well with ey e irritancy . Cells 
are grown in each of the ninety-six wells, treated with test chemicals. 
A reagent is then added that develops color in proportion to the 
extent of cell -growth inhibition. 
There are several in vitro techniques; they differ in the type of material being 
cultured and the duration of the culturing. Subcellular fractions contain parts of cells 
or the entire contents of disgorged cells. Short-term cellular systems contain cells and 
tissues that are cultured less than twenty-four hours. These diverse systems contain 
isolated cells suspended in a fluid medium, tissue derived from biopsies, "tissue 
slices" from whole organs, or whole organs treated with special chemicals. Tissue 
culture contains cells and tissues that are nurtured for at least twenty-four hours. 
Tissue culture is a prominent part of current research in alternatives. L iving 
tissue is cultured in a medium that supplies nutrients. More sophisticated culturing 
schemes can better mimic the workings of the whole animal by supplying chemical 
substances that regulate cell function, such as hormones. 16 
Tissue culture includes cell culture and organ culture. In cell culture, a tissue 
fragment is dissociated into its component cells. The first generation of these cells is 
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a primary cell culture. If the cells grow and multiply indefinitely, a continuous cell 
line is established. 
In organ culture, the emphasis is not on the growth and reproduction of 
isolated cells but rather on the maintenance of the tissue's three-dimensional 
structure and function. Organ cultures are relatively short-lived and do not 
propagate themselves, so fresh samples are needed each time cultures are set up. This 
may necessitate killing animals. However, as in cell culture, many organ cultures 
usually can be derived from one animal and hence these cultures qualify as 
reduction alternatives. 
The placenta is a readily available organ that can be studied in vitro after it is 
discharged with the rest of the afterbirth. The placenta is a complex, multipurpose 
organ that is highly susceptible to drugs and chemicals, which makes it a suitable 
system for pharmacological and toxicological studies. Its potential as an alternative is 
conveyed in the title of a recent book, Placenta- A  Neglected Expen·mental 
Animal. 17 A research program aimed at substituting placentas for animals in toxicity 
testing is being coordinated at the University of L ondon and financed by the L ord 
Dowding Fund for Humane Research.18 
In vitro techniques have several advantages over in vivo techniques, that is, 
studies of intact organisms. They enable tissue, cells, or subcellular components to be 
studied apart from confounding influences of other body systems. Because chemicals 
of interest can be added directly to the culture, much smaller amounts of chemicals 
are needed. This sensitivity was the main reason why the National Cancer Institute 
(NCI) recently launched a $2.5 million screening program for anti-tumor agents. An
NCI representative noted that "the materials that we are typically looking for are 
trace constituents, so the in vivo model is inherently an insensitive one and we may 
miss, in most cases, our most interesting lead. " 19 Cells to be cultured can first be 
cloned to achieve genetic homogenicity or be manipulated in other desired ways and 
then studied. 
Although in vitro techniques are ideally suited to studying biological systems in 
isolation, they can also be designed to reflect interactions between systems. For 
example, tissue from one organ can be exposed to specific hormones produced by 
other organs, or a potentially toxic chemical can be incubated with liver cells to 
determine whether the liver detoxifies the chemical before it can exert any toxic 
effect on other cells. Although in vitro systems can be made more complicated in 
this way, the strengths of the in vitro approach are its simplicity and precision. 
While it is true that in vitro studies are ill-suited to model complex systems and 
hence will never fully replace in vivo studies, the converse is also true. 
In vitro technology can be applied to study virtually any type of cells in the 
body. The practical problem of not being able to grow specialized cells has now been 
large! y solved. 20 
Examples of in vitro procedures follow: 
• The L AL test, described earlier, is an in vitro test that uses subcellular
components obtained from horseshoe crabs to determine whether intravenous fluids 
will induce fever. This newly introduced test is already being conducted more than a 
million times annually. 21 
• A tissue-culture technique has been developed to standardize th� potency of 
rabies vaccine. 22 This vaccine consists of a weakened, live form of the rabies virus. 
The potency of each batch of vaccine must be standardized so that it is not too 
strong or too weak. Potency is currently evaluated in an L D50 test on mice, but the 
twenty-one- day test period makes this test impractical. Confounding factors, such as 
unrelated deaths and differential susceptibility of animals to the virus, can increase 
the variability in test results. The alternative, tissue-culture test is as sensitive as the 
mouse test but takes only twenty-four hours to conduct. The basis for the test is a 
sophisticated technique that involves fluorescent antibodies. When these antibodies 
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attach to their targets (in this case, cells infected with rabies virus), the resulting 
complex is easily detected and quantified under a microscope, owing to the 
antibody's fluorescence. The developer of the test recommends it as a replacement 
for the mouse test. 
• A new in vitro test for diagnosing infant botulism is at the threshold of
clinical application. Developed by M. Dezfulian of the Johns Hopkins Center for 
Alternatives to A nimal Testing, the test probably will replace the conventional test 
for this disease, which requires up to 200 mice. Infant botulism results from a 
chronic intestinal infection by bacteria, which produce a toxin that causes extensive 
damage. It is now the most common form of botulism, outranking acute infection 
from food poisoning. 
The disease is diagnosed by culturing stool samples. In the conventional test, an 
extract from this medium is injected into mice. It is fatal if the botulism toxin is 
present. In the alternative test, the toxin is detected by an in vitro reaction with 
antitoxin antibodies. In its present formulation, this procedure does use animals 
(rabbits) to produce the antibodies. However, this step is fairly harmless and 
produces enough antibody from one rabbit to substitute for hundreds of mice. The 
alternative test has several advantages over the conventional test. The mouse bioassay 
is generally considered to be cumbersome and inconvenient, while the alternative test 
is easily carried out in routine clinical laboratories. Its results are obtained overnight, 
in comparison to seven to fourteen days in the bioassay. The alternative test has the 
added advantage of not being confounded by any lethal substances, other than the 
botulism toxin, that might be present in stool.23 In Dezfulian's testing,24 the new 
procedure proved as effective - if not more so - than the mouse test. 
• Tissue-culture techniques have reduced the demand for laboratory animals in
virus research. A nimals are no longer needed as living test tubes to culture viruses. 
Tissue-culture techniques can also be used to screen substances for their potential as 
antiviral drugs. For example, one pharmaceutical company used mice to screen for 
antiviral drugs. The company later added a cell culture as a primary screen and organ 
culture as a secondary screen and retained mice as a final screen. In 1963, the 
company screened one thousand substances per year using approximately sixteen 
thousand mice. Twelve years later, after adopting in vitro techniques, it screened 
twenty-two times more substances per year using approximately one tenth the 
number of mice!25 
• Tissue-culture techniques are at the forefront of basic research in
biomedicine, particularly in studies of the immune system. According to the 
National Academy of Sciences, "Major recent advances in our knowledge of the 
immune system made possible by cell cultures would have been virtually impossible 
to achieve in intact vertebrates."26 The same report notes the following: 
It is clear that the study of in vitro antibody responses has led to a major 
portion of our understanding of immune system responses. Using an in
vitro system, one can make 200 to 400 cultures from a single mouse. If 
these same studies were to be conducted in vivo, they would require 200 to 
400 mice to achieve the same number of observations. 
Cell-culture techniques have recently been applied to behavioral research in 
studies of the biochemical basis of depression and mania. Human skin cells were 
maintained in culture and assessed for their ability to bind to various 
pharmacological agents. 27 The cultured cells of manic- depressives and their relatives 
exhibited biochemical properties markedly different from the cells of persons without 
a family history of manic depression. One commentator characterized this research as 
"a step forward, applying to psychiatry the techniques of tissue sampling and cell 
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culture that have been of great value in characterizing molecular abnormalities 
num_erous m�dical diseases. "
28 Imaginative research such as this expands the sco�: of 
in vitro studies beyond what was formerly attempted. 
Mathematical and Computer Models 
Modern approaches to biomedical research are increasingly incorporating the 
language of mathematics into their descriptions of living systems. Mathematical 
approaches are being applied in studies of all levels of biological organization, from 
interactions among molecules to interactions among organisms. In these approaches, 
existing information is used to describe the system under study in mathematical 
terms. The resulting mathematical model usually is a simplified version of reality but 
is, nonetheless, helpful in understanding complicated systems, especially those in 
which several variables influence an outcome. 
As an illustration, consider the outcome to be the degree to which various 
chemicals are toxic. Toxicity is likely to be influenced by several factors, including 
the size and shape of the chemicals' molecules, the presence of certain reactive 
groups, the way reactive fragments are linked together, and the chemicals' affinity 
for fats versus water. Each of these factors can be represented mathematically by one 
or more variables or "parameters." In this example, toxicity would be modeled on 
the basis of the chemicals' structure, composition, and physical/ chemical properties. 
Toxicity data on already-tested compounds could be used to help predict the toxicity 
of unknown compounds. Models such as these are known as structure/activity 
relationships (SARs) because chemical structure is used to predict activity, in this 
case, toxicity. 
Once mathematical models are formulated, they must be verified to see if they 
accurately reflect the relationship under study. In toxicity testing, this verification 
procedure is known as validation. In the area of research, verification usually involves 
a procedure known as simulation. In a simulation, one or more parameters in the 
model is changed to determine if the response is similar to that seen in the living 
system. If dissimilar responses are obtained, the model can be refined or entirely 
reformulated. Because simulations usually are too complex to conduct by hand, 
researchers often turn to computers. Computer simulations are useful not only in 
validating models but also in suggesting new mechanisms and hypotheses for 
further study. 
V. Computer modeling equipment used by Dr. James Walker in 
physiology exercises that have traditionally been performed on
dogs. These two monitors show data in graphic and tabular form.
Modeling is now an intefral part of research in many laboratories, particularly in 
the pharmaceutical industry.2 Unfortunately, its more widespread application is 
hampered by a general lack of mathematical and computer skills among researchers 
and the cost of computer equipment and commercially available programs. NIH has 
recently taken steps to overcome these problems. It financed the creation of the 
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Biomedical Simulation Resource at Duke U niversity Medical Center, which makes its 
facilities for building and examining mathematical models available nationally to 
biomedical researchers. The resource offers technical advice and access to computers 
and programs either at the facility or over a telephone data network. 30 
Computer models serve at least two general purposes in alternatives research. 
F irst, they can substitute for animal tests, in some cases. The extent to which models 
need to be backed up by animal tests depends on how well the models perform 
during validation. The better the performance, the less the need for back-up tests. 
In toxicity testing, models are likely to bring major reductions in animal use because 
existing information from animal studies on thousands of compounds can be applied 
toward predicting toxicity of closely related compounds that have not been tested. 
The outlook is not quite as bright when models are applied in new areas of research, 
since the results from the simplified models will have to be checked in the far more 
complex living system. 
Second, mathematical models can make animal research more humane by 
identifying promising avenues of investigation and thereby preventing fruitless 
animal research or by estimating the toxicities of a closely-related series of 
compounds, so that only the least toxic compounds will be developed and tested 
on animals. 
These functions of mathematical models are illustrated in the following 
examples and in the following chapter. 
• Mathematical modeling has been used to determine the molecular
characteristics of cancer-causing chemicals. One hundred and fifty structurally related 
chemicals were analyzed; each had been found previously to be either carcinogenic or 
noncarcinogenic in animal studies. The model was an attempt to distinguish between 
these two sets of chemicals based solely on molecular structure.31 U sing the statistical 
technique of pattern recognition known as discriminant analysis, researchers correctly 
classified ninety-seven percent of the compounds. Such studies should encourage 
further research in predicting toxicity from molecular structure. Success in these 
endeavors will lead to a decrease in animal use for predicting toxicity. 
• The potential value of mathematical modeling to cancer research has also
been illustrated by Charles Delisi and coworkers at the National Cancer Institute. 
According to a recent article, Dr. DeL isi's 
computer program . . .  analyzed the response of the immune system to 
cancer. F rom information they gave the computer about tumor growth and 
antibody production, it calculated that the immune system could not only 
fight cancer growth but stimulate it as well. Researchers know that now, 
says Delisi, "but if our model had been around ten years ago, it could 
have predicted what it's taken scientists countless man-hours and animals 
to figure out. This is the value of mathematical modeling - it comes up 
with things that you might otherwise miss."32 
• Mathematical modeling of malaria research illustrates the potential value of
modeling in guiding research efforts. This modeling was a retrospective analysis of 
results from the testing of potential anti-malarial drugs. A large-scale testing 
program had been conducted on mice at the Walter Reed Army Institute of 
Research. Development of a structure/ activity relationship for a certain class of 
chemicals synthesized early in the program showed retrospectively that further 
research on this class was futile, yet many other chemicals in this class were 
synthesized and tested in mice. This analysis suggests that prospective use of 
mathematical modeling will prevent much futile animal experimentation. 33 
• A computer program developed by thirty scientists at the Los Alamos
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National L aboratory is an ambitious attempt to duplicate the complex physiological 
systems of the human body. 34 The program is known as "HU MTRN," sho� �or 
human transport. It is a data bank that gives simultane�>Us ac�ess t? ten million . pieces of information on what happens �hen any _ chemically �dentifia�le substance ts 
taken into the human body. HU MTRN is dynamic to the pomt of bemg 
programmed to eat, breathe, perspire, defecate, grow,_ develop sexually_. age, work, 
and die. A scientist associated with the HU MTRN proiect has called this program 
"the cutting edge of modeling technology." In one study, HU MTRN suggested_ that, 
in most kinds of nuclear accidents, teenagers and young adults would be the highest 
risk group in suffering long-term effects. The developers of HU MTRN refer to this 
mathematical model as the "research rat of the future." 
Use of Less Sentient Organisms 
The seventy million vertebrate animals used in U .S. laboratories every year have 
well-developed nervous systems and are, therefore, more likely to experience pain 
and suffering than are invertebrate animals and microorg�sms. Invertebrates. include animals without backbones, such as jellyfish, squid, earthworms, and msects. 
Substitution of invertebrates for vertebrates, where feasible, would constitute a 
refinement in virtually all cases. (In some cases, decisions about relative levels of 
sentience will need to be made carefully, as generalizations have exceptions.) 
Similarly, substitution of vertebrate embryos for the more _sentient adults would be arefinement. Substitution of microorganisms such as bacteria and protozoa for 
vertebrates would constitute complete replacement.* 
The principle of using less sentient organisms even applies to pl�ts. P!ants, as 
well as microorganisms and invertebrates, can be used to study baste biolog1Cal 
processes. Two Nobel Prizes in medicine or physiology have been awarded for work 
in plants. Hence, plants, as well as microorganisms, invertebrates, and vertebrate 
embryos, can be considered "alternative organisms." 
Alternative organisms are being used to develop scores ?f alternatives. 35 •3
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Several promising tests have already been developed, _many m_ the field ?f toxicity 
testing. Some will be discussed here; others will be discussed m the secuons on the
LD50 test and the Draize test. 
• A simple test for detecting teratogens (chemicals that cause birth defects� has
been developed using hydras, tiny aquatic animals related to jellyfish. The test is 
based on the observation that chemicals that cause birth defects in animals also tend 
to disrupt normal development in hydras. This test is currently the most promising 
alternative screen for teratogens. 37 
• Plants may replace animals in tests to detect substances that c�use skin
damage in the presence of light. 38 Such substan_ces, termed phot?toxtm, ex�rt their 
effects after being ingested or applied to the skm. Laboratory anunals, paruc�larly 
hairless mice, are currently used routinely in phototoxicity tests. The alte!nauve test 
is based on the observation that phototoxins inhibit the growth of yeast m the 
presence of light. The test, developed by F. Daniels, yields results th_at are similar to 
those from the mouse test when testing substances that are phototoxtc when applied 
directly to the skin. Other alternative tests need to be dev�loped to detect s�b�tances 
that are phototoxic after being ingested. Further research is needed on Damels s test 
to corroborate and extend the encouraging results found to date. 
*Research on microorganisms is sometimes characterized as in vitro _because these organisms are so small 
they can be cultured in laboratory containers. _A differem classificauon ts adopted here m order to 
emphasize the affinity between research on m1croorgarusms arid research on other orgarusms of limited 
or no sentience. 
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VI. The Ames test: each plate contains a culture medium
incapable of supporting the tester bacteria unless the latter 
undergoes mutation. In A, bacterial colonies, seen as white 
dots, descended from bacteria that mutated spontaneously; in 
B-D, mutation was increased by adding chemical mutagens.
•. The Ames test uses _bacteria to detect mutagens ( chemicals that induce genetic mut�tions). Because mutations are often associated with cancer production, the Ames 
test 1s used as a screen for carcinogenicity. This well-researched test is now a classic 
example of an alternative. It uses a specially prepared strain of the bacterium 
Salmonella typhimun:um. The_ culture medium is designed so that only bacteria that 
have undergone certam mutations are capable of growing. 
In addition to bacteria, the Ames test also makes use of in vitro culture of liver 
enzym�s- Rats are the recommended source of livers, although human cadavers have 
potential. 39 Whatever the source, the culture contains the microsomal structures 
mentioned in the test's alternate title, the Salmonella/Microsome test. Potential 
�utagens_ are i_ncu_bat�� wi�h this culture in or?er to s�ulate a process known as 
metabolic activation, which normally occurs m the ltver (and to a lesser extent in 
other organs) of intact animals. Unless activated, mutagens might not exert their 
effects and would thereby escape detection. 
. The Ames test has been improved continually since its introduction and now 
gi�es res�lts com.l?arable t<;> those_ of �nimal bioassays. It has the added advantage of 
bemg quick and mexpensive. It is widely used as an initial screen often in 
combination with other short-term tests, and therefore has reduc�d the demand for 
laboratory animals in carcinogenicity testing. A considerable number of mutagens 
fu�t detected by the Ames test have been shown subsequently to be carcinogenic in 
animal tests. 40 
Abo_ut ni�ety p�rcent of �nown carci�ogens can now be detected by short-term 
mutagemc testmg usmg battenes of tests. These tests are inexpensive and can be 
conducted in one to five days. 
38 
·SEC T I O N  V ·
Physical and Chemical Techniques 
Physical/ chemical techniques exploit instruments and chemical procedures, not 
animals, to analyze the physical and chemical properties of drugs, toxins, body 
chemicals, and other substances. For instance, high performance liquid chromato­
graphs and mass spectrophotometers are physicochemical instruments that accurately 
isolate, identify, and measure the amount of a given substance in complex biological 
mixtures. In high performance liquid chromatography, the test substance is forced 
through a column of silica and different chemicals pass through at different speeds. 
This characteristic is used to analyze precisely the components of the substance. 
Physicochemical techniques are replacements when used instead of animals to 
assay substances. They are reductions when they perform their analyses better than 
cruder methods and thereby require fewer animals per experiment. Numerous 
technical improvements can be considered as physicochemical reduction alternatives. 
For example, a device is now available that divides a one-microliter sample (which 
itself is tiny) into one thousand subsamples, each of which can be analyzed 
biochemically. 42 It is easy to see how the use of such an instrument could reduce the 
number of animals needed as sources of tissue samples. 
• Physicochemical techniques have replaced the use of animals in assays for 
vitamins A ,  D, and E and for "biologicals" such as the hormone oxytocin. In the case 
of vitamin D3 , the new technique involves high performance liquid chromatography 
and provides a simpler, quicker, and cheaper alternative to the animal bioassay. The 
latter procedure involved inducing a vitamin D3 deficiency (rickets) in rats and 
administering D3-rich substances such as cod liver oil over several weeks - a laborious 
and time-consuming method.43 
• Physicochemical techniques have replaced the use of rabbits in human
pregnancy tests. Nowadays, one can obtain pregnancy diagnostic kits from the corner 
drug store. These kits contain simple materials to screen a potential mother's blood 
or urine for a chemical associated with pregnancy. 
Other Techniques 
Other techniques or systems may be used to replace, reduce, or refine the use of 
animals in research. These include mechanical models, veterinary patients, and 
computer-aided drug design. 
Mechanical Models: animals are sometimes used to study effects of accidents 
such as vehicle crashes and specific injuries such as burns. Mechanical models are 
being developed that might replace animals in these studies. For example, an 
artificial neck developed by General Motors is being used in car-crash simulation 
tests, and a human simulator known as Thermoman is being used to test potential 
burn risks with different garments.44 
Veterz·nary Patients: just as clinical studies of humans can reduce the demand for 
laboratory animals, so, too, can clinical studies of animals. A nimals are susceptible to 
many of the same illnesses and injuries that plague humans. A nimals that are 
already sick could be studied while undergoing treatment, and the resulting 
knowledge could benefit human health. (Of course, the primary concern in these 
studies should be the animals.) Clinical studies of animals could reduce the 
number of laboratory animals that are deliberately sickened or injured in 
experimental studies. 
Prof. Calvin Schwabe, a respected research veterinarian, argues that both clinical 
and epidemiological studies of animals are being virtually overlooked as potential 
resources for understanding human diseases. The relevance of spontaneously 
occurring diseases in animals to medical research on humans is unappreciated. A 
consequence of this, according to Schwabe, is that most of the research in compara­
tive medicine that is being conducted by physicians is focused upon the potentially 
least rewarding approach to animal diseases, namely, studying artificially induced 
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rather than spontaneous diseases. Veterinarian Michael Fox, in recounting Schwabe's 
view, calls for greater collaboration between veterinary and medical researchers. 45 
Computer-Aided Drug Design: discovering new drugs is largely a 
trial-and-error process, costly in terms of time, money, and animals. It takes eight 
years, on average, to screen a new substance from the seven thousand to eight 
thousand novel compounds created each year and to bring it into medical practice. 46 
Fortunately, methods are being developed to replace this shotgun approach with the 
more directed approach of computer-aided drug design. Three-dimensional 
computer graphics and the theoretical field of quantum pharmacology are being used 
in efforts to design drugs with particular specifications. These efforts are based on 
the lock-and-key mechanism of drug action; that is, drugs must be the right shape 
and composition in order to "dock" with their targets and trigger their effects. Color 
graphics help visualize this process. 
A lthough computer-aided drug design is in its infancy and is highly theoretical, 
there are indications that progress is being made. Several "drug designers" have been 
included on new drug patents for aid in discovering drugs.47 A new drug being 
tested clinically for effectiveness against high blood pressure was designed with 
computer methods.48 Perhaps it is not surprising, then, that several pharmaceutical 
companies now employ such "drug designers." 
Much of the work in computer-aided drug design is apparently being conducted 
in Britain, where it has received some financial support from the Lord Dowding 
Fund. However, researchers at the University of Pittsburgh are collaborating with 
British researchers in attempts to use computer-aided methods to design a drug to 
treat sickle-cell anemia.49 New efforts such as these hold great promise for reducing 
animal use by revolutionizing the process of drug discovery. 
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Case Studies : 
The LD50 Test 
And the Draize Test 
MUCH OF THE public outcry against the use of animals in toxicity tests has 
centered on the 1D50 test and the Draize test. It is not surprising, therefore, that 
much of the research into developing alternatives in toxicity testing has been directed 
at these two tests. Substantial progress in this research has been made during the last 
five years. 
The 1D50 Test 
The 1D50 test was developed in 1927 to standardize the potency of potentially 
poisonous substances destined for human use, such as diphtheria toxin, digitalis
· extract, and insulin. A lthough not originally designed to do so, the test gradually 
became incorporated into routine toxicity programs for testing new chemicals. 
Government regulations in the U.S. and abroad specified the 1D50 test for 
evaluating new drugs, food additives, cosmetics, household products, industrial 
chemicals, and pesticides. Each year in the U.S., four to five million rats, mice, 
guinea pigs, and, less frequently, rabbits, dogs, and primates, are subjected to 
this test. 1 
In the 1D50 test, test substances are force-fed, inhaled, injected, or applied to
the skin of animals. Of these variants - the oral, inhalation, injectable, and dermal 
1D50 tests, respectively - the oral 1D50 is the most common. It produces signs of 
poisoning including bleeding from the eyes, nose, or mouth; labored breathing; 
convulsions; tremors; paralysis; and coma. 
The classical 1D50 test uses large numbers of animals to derive a numerical
index of toxicity (the 1D50 value). This approach has two major scientific problems. 
First, the test is of limited value in protecting human health. This limitation stems 
primarily from an overemphasis on the 1D50 value. Sometimes, little or no . additional information (such as poison symptoms, body organs affected, and specific
cause of death) is gathered. This important information could be derived from
relatively few animals. A ccording to D.V.W. Parke, the "counting of cadavers" 
should be replaced by full clinical and postmortem studies using fewer animals.2 
Even when the 1D50 value is supplemented with clinical and pathological 
information, public health officials can still be at a loss to infer the maximum safe 
dose of the test substance in humans. The 1D50 provides the median lethal dose, 
not the safe dose. Moreover, the lethal dose, as ill-suited a measure as it is, still has 
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VII. Rat being force-fed a pesticide in an W50 test 
to be extrapolated from, say, rats, to humans. This extrapolation is nearly 
meaningless. A ccording to toxicologist G .  Zbinden of the University of Zurich: 
The marked species differences in acute toxicity are well recognized, 
making it impossible to predict the human lethal dose from the results of 
animal experiments. With such enormous variations between species, it is 
clear that the knowledge of the 1D5 0 in a mouse or a rat does not provide 
much support for the prognosis in a human case of acute poisoning. 3 
A second problem with the classical 1D50 test is its unnecessary precision. Large 
numbers of animals are used to derive a precise estimate of 1D50, yet that estimate 
can be applied to humans in a rough manner only. According to Rowan, "If the 
1D50 figure of a compound is 100 milligrams per kilogram of body weight for a 
mouse, it could easily be anywhere between 10 and 10,000 milligrams per kilogram 
body weight for a human being. "4 
The illusary precision of 1D50 values applies to animals as well as humans. 
Calculated 1D50 values for the same chemical can vary substantially among 
laboratories (inter-laboratory variation) and among laboratory animal species 
(inter-species variation). For example, a study of inter-laboratory variation was 
conducted under the auspices of the European Economic Community.5 Sixty-five 
laboratories were instructed to determine the rat oral 1D50 for each of five 
chemicals. LD50s were determined separately for males and females, as is customary. 
The calculated values varied from four- to twelve-fold in males and three- to 
seven-fold in females. Similar inter-laboratory variation was found in another 
comparative study.6 
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This variation is not surprising given that the 1D50 value depends on a host of 
biological and extraneous factors. A ccording to Zbinden, these factors include 
.. .  species, strain, sex, age, and weight of the animals, abundance and 
composition of diet, volume and speed of administration of the test 
substance, vehicle, solubility, and particle size, concentration, ambient 
temperature, housing conditions, and even the seasons of the year. This 
means that the 1D50, even if it is determined with high precision with a 
large number of animals, is not a biological constant.7 
The precision of the classical 1D50 test is also called into question by regulatory 
practice. Most 1D50 testing is conducted according to regulatory guidelines. 
Ironically, the same guidelines that call for precision usually specify that 1D50 values 
are to be lumped in limited numbers of broad categories for labeling purposes. 
Thus, all of that precision, gained at such cost in animal suffering, is lost 
in categorization! 
These scientific problems with the classical 1D50 test provide a compelling 
rationale for developing and using alternatives. Equally compelling is the ethical 
problem - the suffering and death of millions of animals in a test of such dubious 
value. Several alternatives to the classical 1D50 test are available. They could reduce 
the demand for animals, as well as save time and money, without compromising 
human health. 
Some of these alternatives are modifications that would require fewer animals: 
• One test uses six to ten animals to determine the Approximate Lethal Dose 
(ALD). This test was discussed earlier as an illustration of reduction alternatives in 
toxicity testing. 
• The Limit test involves giving a small group of animals ( ten to twenty) a
single dose of a test substance. If no ill effects are seen, no further testing at higher 
doses is required. The accepted maximum dose for the test depends on the nature of 
the substance being tested. 8 The Limit test is especially useful for relatively harmless 
substances, which would necessitate unrealistically large doses in the classical test. 
• In the Up-and-Down test, each animal receives a single dose, but that dose
changes as the six or so animals are sequentially tested. The dose is lowered after 
signs of severe toxicity develop or is raised after an animal survives on� week without 
such signs. The resulting information is evaluated in a commonly available computer 
program. The test yields a reasonable estimate of the 1050.9 
• Other techniques also use fewer animals than the classical 1D50 and yet yield
1D50 figures of satisfactory precision. These include the "moving averages" technique 
and a graphical method suggested by Molinengo. 10 
These modifications of the 1D50 test use substantially fewer animals than the 
classical test and, therefore, qualify as reduction alternatives. The Limit test, by its 
very nature, is also a refinement alternative in that it reduces exposure of animals to 
pain-inducing doses. All of these modifications could qualify as refinei:nents if 
animals that were acutely suffering and dying were instead painlessly killed and 
counted among those that died or exhibited severe toxic reactions. 11 This refinement 
was recently recommended by the British Toxicological Society. 
Many toxicologists who conduct acute toxicity tests such as the 1D50 make at 
least some use of these alternatives, especially the Limit test. 12 The U.S. cosmetics 
industry substituted the L imit test for the classical 1D50 test and there�y �educed 
animal use by seventy-five to ninety percent, according to a trade association 
survey . 13 A nd Allied Corporation has abandoned the classical 1D50 test in favor of 
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the "Up-and-Down" test. A nimal use was cut in half. This innovation and others 
are yielding more information, cutting costs, and reducing the stress of those animals 
that are used.14 
These examples may represent just the tip of the iceberg; the consensus among 
participants at the second symposium of the Center for Alternatives to A nimal 
Testing was that reduction alternatives could completely replace the classical 
1D50 test. 1 ) 
Alternatives to the classical 1D50 are not limited to modifications of the test 
itself. They also include mathematical models, in vitro techniques, and 
alternative species. 
Mathematical models are being developed to predict 1D50 values without using 
animals. The most promising of these models is that of Kurt Enslein and his 
colleagues at Health Designs, Inc. The model predicts the oral 1D50 values for rats, 
based solely on a chemical's structure and properties. The model, created through an 
analysis of nearly two thousand chemicals that had already been tested in rats, was 
evaluated by generating predictions on the 1D50 values of another 900 compounds 
that had already been tested. The predicted values were similar to the actual values 
obtained in animals. 
The researchers concluded that their model could be used competitively with the 
rat 1D50 test. It has many advantages: elimination of unnecessary animal testing, 
lower cost, faster response, and greater repeatability. K. Enslein suggested a number 
of applications: (1) estimating the doses to be used in animal-based 1D50 tests (this 
application could spare animals from being tested at doses that are too small or large 
to be meaningful); {2) selecting least toxic compounds by obtaining estimated LD50s 
on similar compounds before they are synthesized, then ranking these estimates to 
decide which compounds to investigate further ( this application could spare animals 
from being tested with highly toxic substances); and (3) supplying data for any acute 
toxicity studies as needed. 16 
The major limitation of the model is that it cannot, as yet, generate estimated 
1D50 values for all compounds, owing to technical problems. Enslein and his 
collaborators have discussed this and other limitations of their model, adequately 
addressed their critics, and discussed future plans to improve the model and render it 
more understandable to toxicologists. 17 This latter development will hasten the 
model's evaluation and possible application. 
The model is likely to be used initially as a preliminary screen, backed up by 
animal testing. During this period, the model could be improved. If it then inspires 
confidence, it may totally replace 1D50 testing in animals. 
Cell-culture alternatives to the 1D50 test are being developed by a research 
program coordinated by FRAME. 18 The program involves four laboratories in the 
United Kingdom and is financially supported by numerous commercial and 
nonprofit organizations. The aim of the program is to develop a tier approach to 
acute toxicity testing: 
Level 1: In vitro testing for gross toxic effects on fundamental properties of 
cultural cells, 
Level 2: In vitro testing for specific toxic effects on particular target organ 
cells, and 
Level 3: In vivo testing, if necessary. 
Work on this program is in progress. Preliminary results on Level 1 are 
encouraging. The fundamental property being examined is protein synthesis by 
human embryonic cells. In this procedure, toxic chemicals administered to these cells 
inhibit protein synthesis. The test yields an 1D50 value, the dose causing fifty 
percent inhibition of protein accumulation. 1D50 values are well correlated with in 
vivo 1D50 values. Although cell-culture tests such as this one may never completely 
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replace in vivo testing, their judicious use clearly has great potential. 19 
A nother potential alternative to the 1D50 test involves the use of less sentient 
organisms. U sing a series of alcohol compounds as test chemicals, researchers recently 
obtained an excellent correlation between 1D50 values in mice and inhibition of 
movement in tubifex worms. 20 These findings need to be extended through the 
testing of other compounds that have already been tested on animals but not yet 
tested on worms. 
G iven the inadequacies of, and the alternatives to, the classical 1050 test, it is 
not surprising that support for the test is eroding in all quarters. Even toxicologists 
have criticized it. Dr. S.B. deC. Baker stated that acute studies such as the classical 
1D50 "are of little use and are expensive in animals. The main information they give 
is an indication of the . . .  dose required to commit suicide. "21 Zbinden called the 
1D50 "a ritual mass execution of animals."22 Dr. D.P. Rall, director of the United 
States-based National Toxicology Program, called the 1D50 "an anachronism. I do 
not think the 1D50 test provides much useful information about the health hazards 
to humans from chemicals . . . .  "23 The Pharmaceutical Manufacturers A ssociation, 
which represents 149 research-based pharmaceutical companies in the United States, 
stated that "A dvances in toxicity testing now make it possible to conduct most 
drug-safety evaluation without the Classical 1D50 test."24 Even the National Society 
for Medical Research, which promotes and defends the use of animals in biomedical 
research, has backed away from the LD50. Its new position is that "The routine use 
of the quantitative 1D50 test is not now scientifically justified . . .  :m 
Despite these statements, the classical 1D50 test has not been abandoned. A 
1983 survey of toxicologists who conducted acute toxicity tests revealed that eighty 
percent used the classical 1D50 test. 26 
Perhaps the only scientifically legitimate use for the classical 1D50 test is in rare 
cases in which drugs have a narrow margin of safety, so that toxic levels have to be 
precisely determined. 27 So why does the widespread use of the classical 1D50 test 
persist? The main reason cited by the manufacturing and testing companies that 
participated in the 1983 survey was to satisfy regulatory requirem<;nts.
28 Of cours<;, by 
satisfying regulations, these companies may feel better armed agamst damage claims 
brought by consumers. Perhaps these companies have difficulties in breaking an old 
habit. For their part, regulatory agencies also seem worried about consumer backlash 
and seem to be plagued by bureaucratic inertia. 
A major regulatory obstacle for products marketed internationally is the 
Organization for Economic Cooperation and Develop�ent (�ECO). _ OECD . guidelines require that the 1D50 test be conducted pnor to mternauonal marketing 
of products. Companies whose products have any chance of being marketed overseas 
may automatically conduct 1D50 tests, regardless of whether or not the products are 
eventually marketed internationally. 
The Draize Eye-Irritancy Test 
The Draize test is a method of assessing the eye- irritancy potential of various 
substances including cosmetics, toiletries, household products, ophthalmic drugs, 
pesticides, and industrial chemicals. The test was developed following passage of the 
Federal Food, Drug, and Cosmetic Act of 1938, which mandated (among other 
things) that cosmetics be free of substances poisonous or deleterious to the user. 
Today, the test is a routine component of toxicology p�ograms '.1-°d regula�ory 
evaluations worldwide. However, prospects for developmg and 1mplemenung 
alternatives appear promising. 
The Draize test is performed almost exclusively on albino rabbits. It� �r?cedures 
have been modified several times since its adoption. A fixed dose (0.1 milhhters or 
O . 1  grams) is placed inside the lower lid of one eye of six to eighteen rabbits. 29 The 
lower and upper lids are then briefly held together to d�stribute the te�t substance on 
the eye surface. The other eye is left unused for comparison. The rabbits are 
restrained during the procedure and later immobilized in stocks to prevent them 
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VIII. Rabbits immobilized in stocks as part of a Draize test 
from rubbing or scratching their eyes. 
The rabbits' eyes are examined at specific times after exposure to the test 
substance (e.g., at 1, 24, 48, 72, and 168 hours). Damage to different parts of the 
eye is rated on separate scales. The maximum scores for damage to the cornea, 
conjunctiva, and iris are eighty, twenty, and ten points, respectively. These scores are 
added to yield an overall score for eye injury. 
Eye irritation in the Draize test usually consists of reddening and swelling of the 
conjunctiva and iris and clouding of the cornea. Eye damage can be readily 
anticipated when substances such as hydrochloric acid, formaldehyde, alcohol, 
industrial solvents, drain cleaner, laundry soap, dish washing compounds, and 
shampoos are tested. Animals that survive the test with minor injuries are sometimes 
used for other laboratory studies, such as skin-irritancy testing, before they 
are killed. 
The Draize test undoubtedly has been of some help in deciding whether or not 
substances are safe for human use. However, as the test for preventing ocular injury 
to humans, it leaves much to be desired. A major problem is that the test is 
unreliable. In cases in which particular substances were tested several times ( either in 
the same laboratory or in different ones), it has not been uncommon for the same 
substance to be classified as an irritant in some instances and as a nonirritant 
in others.30•31  
Such differing results may have been caused by variation in the scoring of 
similar degrees of eye damage or the haphazard distribution of the test substance on 
the eyeball. 
The Draize test is also crude. It yields a score that is used to determine whether 
or not a test substance is an irritant - virtually a pass-fail test with an arbitrary 
cut-off point. For many substances, the imponant question for protecting human 
health is not whether a substance is an irritant, but how much of one it is. 
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Perhaps the most significant problem with the Draize test is its questionable 
applicability to humans. There have been many cases of discrepancies between the 
test results and human experience. 32 Rabbit eyes are, in most cases, more sensitive 
than human eyes,33 partly because rabbits produce smaller quantities of tears than do 
humans. (Rabbits possess a nictitating membrane or "third eyelid," which may 
partially compensate for the reduced tear flow.) 
Results of Draize tests are expressed in a way that makes the relevance of those 
results to human experience highly suspect. Test substances can cause different forms 
of eye damage to different degrees, and these are graded to yield numerical scores. 
These scores are weighted to reflect the purported relative importance of damage to 
different eye parts, then added together to yield a composite score. This score is 
interpreted as indicating the degree of irritant potential of the test compound. 
Ballantyne and Swanston have criticized this numerical Draize score as uninformative 
and meaningless. 34 
Several potential alternatives to the Draize test are either being developed or are 
already available. Some are modifications of the Draize test that would reduce either 
the number of animals used or the pain and suffering of the ones used. Others are 
new tests that are potential replacement or reduction alternatives. Eventually, a 
suitable battery of tests to replace the Draize test completely is likely. 
IX. A rabbit's eye damaged in a Draize test 
Let us first consider the modifications of the Draize test that have 
been proposed: 
(1) Use of anesthetics or antihistamines. 
We know that the use of certain anesthetics would not appreciably affect results 
of the Draize test. 
(2) Use of smaller doses. 
The volume of test substance routinely instilled in the eye is 0.1 milliliters (ml). 
Although this dose seems tiny, it is huge in relation to the fluid-holding capacity of 
the eye. Swanston has called this dose excessive and irrational. 3� 
Studies have shown that a smaller dose (0.01 ml) would give better results36 and 
cause less eye damage.37 One such study was prompted by the suggestion from the 
National Academy of Sciences that a smaller dose could appreciably reduce the eye 
damage of test animals to a range more consistent with human experience. 38 Lower 
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doses are not only a humane refinement, but are also likely to yield results of greater 
relevance to protecting human health. 
Using weaker dilutions of a test substance has the same effect as using smaller 
doses. N.J. Van Abbe recommends using dilutions when a substance is likely to 
cause severe reactions at the routine dose. 39 Such dilutions have the scientific 
advantage of enabling finer discriminations to be made from the results. According 
to Van A bbe, the discrimination can also be enhanced by simultaneously comparing 
the results with those from a reference standard. 
(3) Use of noninvasive techniques. 
One technique used to document eye damage in the Draize test involves killing 
the test animals and surgically excising eye tissue. However, several noninvasive and 
nonlethal refinements of this procedure are available. These include measuring 
corneal thickness using an optical device, measuring intraocular pressure using a 
hand-held instrument, and measuring the corneal reflex using a taut string and a 
simple device. 40 If these procedures were adopted, all animals would survive the test. 
(4) Use of fewer animals. 
The Draize test currently calls for six to eighteen rabbits. In a study 
investigating the effect of the number of test animals on the test's precision, 
increasing numbers from one up to six yielded marked improvements in precision.4 1 
However, increasing numbers to nine or twelve yielded "little further benefit when 
set against the increase in animal numbers." Hence, six animals should suffice, in 
most cases. 
A more far-reaching reduction alternative was suggested by Koeter and van 
Vliet, who recommended that a preliminary Draize test be conducted with only one 
animal.42 If severe irritation resulted, testing should stop. If irritation were less than 
severe, a few more animals could be tested, as necessary. 
One can readily imagine other reduction alternatives to the Draize test. Dr. G. 
Flamm of the Food and Drug Administration recently recommended that any 
substance found to be an irritant at a low dosage should not be tested on more 
animals at higher doses.43 
It is unlikely that the Draize test could be refined to the point where all pain 
and stress were excluded. Even if anesthesia and weak dilutions of test chemicals 
X. A cell culture, enlarged 200 times 
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were used, the rabbits would still be living in stockades, which is undoubtedly 
stressful. Indeed, "rabbits not infrequently break their backs as a result of struggling 
to escape" from the Draize stocks.44 This brings us to consider alternatives that would 
replace, or at least reduce the demand for, the Draize test. 
The most widely known alternative replaces rabbits with chicken eggs. A portion 
of the eggshell and adhering membranes is removed from a fertilized egg when the 
embryo has developed for two weeks. This procedure exposes the "chorioallantoic 
membrane" (CAM), which surrounds the embryo. A small amount of a potential 
irritant is applied to a section of the CAM. A positive response can include 
cloudiness, inflammation, and proliteration of blood vessels, but since the CAM has 
no demonstrable nerve supply, the embryo feels no pain. 
Initial results from the CAM test show a good correlation with results from the 
Draize test.4) This promising alternative is now in the "validation stage" and is being 
funded by various animal-welfare organizations in the United States. 
• 
XI. The chorioallantoic membrane (CAM) test: test chemicals are placed on








Many potential alternatives to the Draize test involve in vitro systems. One is an 
organ culture of isolated eyes. Eyes can be obtained from human or animal cadavers, 
especially from sources such as slaughterhouses. An example of this organ-culture 
method is the Enucleated Rabbit Eye test, which has yielded promising results. The 
strengths and limitations of this type of test have been discussed by 
D.W. Swanston46 and M. York.47 
A nother organ-culture system involves isolated corneas, as distinct from entire 
eyes. 48 Rabbit or bovine corneas are incubated with suspected irritants. Irritancy is 
inferred from changes in corneal thickness, ratio of wet weight to dry weight, 
microscopic anatomy, and corneal enzymes. 
Other potential in vitro alternatives to the Draize test involve cell-culture 
systems. The cells for these tests are derived from a variety of sources, including the 
human cornea, mouth lining, and blood (leucocytes); rabbit cornea; rat abdominal 
cavity; and mouse embryo and connective tissue. In these tests, chemical irritancy is 
inferred from a variety of end points, including cell death, cellular release of 
substances associated with irritation, cell membrane damage, changes in cell 
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movement or metabolism, and the rate of wound healing. Examples of these 
cell-culture alternatives include the Rat Mast Cell assay, the Fluorescin Diacetate test
the Haemolytic Activity test, and a variety of as-yet-unnamed tests.49, )0 ,ll 
The Rat Mast Cell assay is already in limited use by the Johnson and Johnson 
Company. Mast cells are derived from connective tissue and are involved in 
inflammatory responses. The assay monitors the cells' release of the chemical 
serotonin. J. _Mc�ormack reported that "the procedure has a high degree of 
correlation with �n �111? test results. In addition, it is easy to perform, accurate, and 
repeata?le, and it li_m�ts the scope of in vivo testing. ")
2 The assay is used as a screen 
to elimmate severe irntants from in vivo testing. However, only a single class of 
comp?unds w� ev�_uated, so it remains to be seen whether the Rat Mast Cell assay 
has wider apphcabday as a substitute for the Draize test. 
Cell-cultu!e tes�s funded by_ Revlon are producing encouraging results. Two 
such t�sts momtor eit�er anato�mcal changes in cells or_ inh�bition of cellular uptake 
of an important �hem1eal constituent. Rockefeller Umversity researchers obtained 
excellent correlations between the results of the two tests and the Draize test. 
Perhaps the most promising c:ll-culture alternative to the Draize test is being 
developed at the Eye Research Institute (Boston) and Harvard Medical School. The 
test _is based_ on t�� observation that when the surface of a rabbit or human eye 
:ece1v�s � mmor IIlJury, healthy cells migrate over the wound and proliferate to heal 
lt. lrntatm� c_hemicals slow this healing process. To investigate this inhibitory effect, 
researchers mJure two types of rabbit corneal cells in vitro, normal cells and those 
treated with an_ irrit�nt. The rate of wound healing is measured by staining the 
wounds and usmg time-lapse photography. The degree to which a substance slows 
the response is an indicator of the substance's toxicity. 
J?r. A .  Ne_ufeld, one of the developers of this test, recently commented, "Not 
only 1s the Draize t��t a poor way to treat animals, but the in vitro method appears 
to be far more sensitive and far more relevant. ")4 Preliminary results using human 
cells suggest that the methods developed for rabbit cells can be successfully applied 
to human cells. 
!'1- _prom_isin� tissue-c_ulture �ternative to _the Draize test utilizes excised strips of 
ra�bit mtestme. Some sixteen pieces can be isolated from a single animal. When 
sui�ably cultured, these str�ps will contract sp?ntaneously for hours unless chemically 
poisoned. The test determmes the concentration of test chemicals necessary to block 
�fty perce�t of the contractions. This test is based on the premise that some damage 
m the Draize test occurs when chemicals penetrate cells on the eye's surface and 
damage �ells �t low�r levels. The surface cells can be viewed as a penetration barrier 
to chemicals; mtestmal cells mimic this barrier effect. The results of this test have 
comp�ed very _favorably_ with in vivo data. One rabbit could provide enough 
matenal for thuty expenments, and the technique could be used for two-thirds of 
the Draize tests currently performed. )G 
The outlook fo� major changes in routine eye-irritancy testing is bright. 
Researc� on alternatives to the current Draize test is active and varied, thanks largely 
to public outcry over the treatment of animals in this test. Refinements and 
reduction alt�rnatives to the Draize can be implemented immediately. 
Imp_lementat1on ?f replacement alternatives probably will be gradual, as alternatives 
are mcorporated into a suitable battery of tests. 
While the Draize t_est is _st�ll i-?- use, alternatives can be used in a supplementary manner to screen out highly umat1ng substances and to determine doses that will 
yiel? mi!d rea�tions in the Draize test. Before considering any form of eye-irritancy 
testing, mvestigators should ask whether a particular substance needs to be tested at 
all. Certain substances need not be tested because they are almost certain to cause 
eye irritation. These include substances that are highly acidic or alkaline and those 
that are already known to be severe skin irritants.)7 
A s  with the LD50 test, efforts to make eye-irritancy testing more humane 
should be directed to government regulators as well as to product manufacturers and 
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their te_sting laboratori:s. Such efforts should focus on eliminating variables in 
:egul_at1ons that _result m unnecessary replication and on circumventing bureaucratic 
mema to accepting proven alternatives. 
Recall that one reason for the persistence of the classical LD50 test is the claim 
that it is necessary to protect manufacturers against untoward legal action. A similar 
claim has _been made with regard to the Draize test. However, in one legal action 
tak�n against a _manufacturer of a sham]?oo that damaged someone's eye, rabbit-eye 
testmg �as a mmor part of the case. This case (United States v. An Article of 
Cosmettc . . .  Beacon Castile Shampoo . . .  ) merits discussion here because both 
supporters and opponents of the Draize test claim that it supports their arguments. 
. The case was a civil suit brought by the Food and Drug Administration (FDA) against the manufacturer in the wake of an eye injury sustained by a young girl. The 
girl dropped a container of shampoo, and the contents splashed up in her eye. To 
support its case that the shampoo was dangerous and therefore should not have 
been marketed, FDA commissioned a Draize test in rabbits and a study of 
human volunteers. 
Despite the fact that the shampoo injured the rabbits'  eyes, the court ruled 
against FDA and in favor of the manufacturer. In a discussion of this decision, the 
G eneral A c counting Office emphasized that FDA failed to show that "the results of 
test on rabbit eyes can be extrapolated to humans . . . .  ")8 This statement is significant 
because it apparently undermined the manufacturer's defense-against-liability 
argument for conducting the Draize test. 
Unfortunately, the issue of extrapolating from rabbits to humans was not the 
keyston� of the judge's decision. )9 The primary reason for the ruling was that the 
FDA faded to show that the full concentrate of shampoo might get into the user's 
eye under the usual conditions of use and that the user would not automatically 
flush out the eye.60 
Nevertheless, the judge did state that the "rabbit studies, standing alone, do 
not warrant condemnation of this product." The judge refused to accept 
extrapolations from rabbit-test results to human response without confirmatory data 
�rom research on human volunteers. In this case, FDA submitted conflicting and 
mcomplete results of human studies. A lthough a complicated and multi-faceted 
case, the Beacon Castile decision does provide evidence that a court did not find 
rabbit-eye testing particularly helpful in determining the extent of human hazard. 
G iven the judge's comments, it is rather surprising that a spokesperson for The 
Cosmetic, Toiletry, and Fragrance Association (CTFA), a manufacturer's trade group, 
asserted that the case "provides support for use of the Draize test as a reliable 
method of substantiating that a product is safe for eye-area use."61 According to the 
CTFA, the judge reasoned that rabbit eyes are more sensitive than human eyes in 
that t�e former have less capacity to tear and flush away an irritant; therefore, any 
chemical that does not injure rabbits' eyes is not likely to injure human eyes. 
The Cl!A supersensitivity-as-an-asset argument is unsupported not only by the 
Bea.con Castile case, but also by toxicological principles. A lthough supersensitive 
species �� well-suited for c�mfid��tly identifying harmless substances, the strength 
of a tox1C1ty test should be its ability to detect harmful substances. If a test is 
supersensitive, it will overclassify substances as harmful. This would be the 
toxicological equivalent of "crying wolf." The test's results could easily be explained 
away, much as studies identifying cancer-causing substances in laboratory animals 
sometimes are dismissed because the huge doses utilized may cause cancer by 
overwhelming the body's metabolism. Use of a less sensitive species or system could 
be more valuable in protecting human health, as well as more humane. 
51  
SECT IO N 
VII 
Alternatives in Education 
Introduction 
Education accounts for less than ten percent of the current level of laboratory 
animal use in the United States, 1 but this figure belies the importance of 
applying the alternatives approach to education. Scientists of tomorrow will be more 
likely to adopt the approach if they are exposed to it as students. Recently educated, 
young scientists are likely to play an important role in the development and 
implementation of alternatives. 
Even students who have no desire to become scientists may nonetheless benefit 
from exposure to the alternatives approach. These students will come away with a 
better appreciation of animals and a more positive view of scientists' activities. 
According to biology teacher G .  Russell, the power of science without the 
control of compassion and admiration for life is too immense to be applied merely 
for the satisfaction of scientific curiosity. If biology were taught in a manner that 
developed a sense of wonder and of reverence for life, and if students felt inwardly 
enriched from their study of life, these students would formulate as a life-long goal 
the steadfast determination to protect and preserve all life and would bring healing 
to a world desperately in need of it. 2 
These philosophical changes might even motivate some students to consider 
careers in science. 
Recognizing the importance of reaching young students, the American F und for 
Alternatives to Animals in Research supports annual training sessions in in vitro
toxicology for students planning a biomedical career. 
This summary of alternatives in education applies primarily to the college and 
graduate levels, where the challenge for the alternatives approach is the greatest. 
Discussions of alternatives that focus on the pre-college level can be found in several 
compilations of humane biology projects. 3 The challenge for alternatives at the 
post-secondary level is not in devising projects that convey the general principles of 
biology, but in devising ones that convey specific information or confer specific skills. 
Examples include learning surgery without practicing on animals, learning 
comparative anatomy without killing large numbers of animals, or learning the 
effects of common drugs without giving those drugs to animals. 
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Alternatives 
There is a wide variety of alternatives to educational uses of animals. 
(1) Surgical Apprenticeships 
In the United States, medical students practice surgical techniques on animals.
This custom accounts for half of all animals used in medical education.4 A n  
alternative is the British system: medical students in Britain gain their initial 
experience in surgery by observing demonstrations on cadavers . Then comes a clinical 
apprenticeship: students observe experienced surgeons operating on sick humans, 
gradually begin to take part along with the surgeons, and finally carry out operations 
under their supervision. 
The using of animals solely to gain surgical dexterity is prohibited in Britain by 
the Cruelty to A nimals Act of 1876. A ccording to the Royal College of Surgeons of 
England, the prohibition "has not proved an obstacle to the effective training of 
young surgeons in the United Kingdom."5 This view is supported by a recent study 
of British and American surgeons, which indicated that practice surgery on animals 
made no difference to long-term competency. 6 
A simifar prohibition applies to the use of animals in training veterinary 
students in Britain. These students train with experienced veterinary surgeons and 
use animals that need the operations for therapy. According to the British Veterinary 
Association, "The idea of making healthy animals sick for purposes of training is 
totally repugnant to the [veterinary] profession in this country. "7 
Unfortunately, this is not the case in U.S. veterinary schools, where healthy 
animals - primarily dogs and sheep - are subjected to practice surgery. Such 
procedures account for a significant percentage of the animals used in 
veterinary education. 8 
(2) Placentas for Microsurgery
A pprenticeships work well for practicing most types of surgery but are ill-suited
for the new field of microsurgery. Used primarily to reconnect severed fingers or 
hands or to reconstruct badly damaged tissue, microsurgery involves, among other 
things, reconnecting tiny blood vessels. It is not the sort of operation a trainee can 
readily learn at the shoulder of an accomplished microsurgeon. 
For this reason, Britain is considering lifting its ban of practice surgery on 
animals for microsurgery. However, a promising alternative using human placentas, 
funded by the Lord Dowding Fund for Humane Research, is being developed by 
Dr. Paul Townsend, a plastic surgeon at the Frechay Hospital in England. The 
surface of the placenta has blood vessels of various sizes that can provide 
opportunities to practice microsurgery. A pump simulates blood flow through the 
vessels. Unfortunately, the pumped blood cannot clot, and clotting is a primary 
consideration in clinical microsurgery. Dr. Townsend thinks that this limitation can 
be overcome and that placentas can be a replacement for animals in microsurgery 
training.9 
The British newspaper The Guardian has suggested that the British government 
should encourage development of the placenta alternative rather than relax controls 
on animal use in practice surgery. 10 
(3) Computer-Assisted Mannequins 
Carefully designed mannequins can simulate the appearance and selected
responses of humans or animals and, therefore, can play an important role in 
education. Widely cited examples include Sim, the mannequin discussed earlier, and 
"Resusci-Dog," a canine mannequin that teaches cardiopulmonary resuscitation to 
students at the New York State College of Veterinary Medicine. Resusci-Dog, whose 
development was supported by the G eraldine R. Dodge Foundation, is one 
component of a computerized cardiopulmonary emergency simulator that confronts 
students with various "emergencies." It also evaluates the students' diagnoses and 
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· XII. Resusci-Dog is a canine mannequin used in teaching 
cardiopulmonary resuscitation at New York State College of 
Veterinary Medicine. 
treatments and causes "patients" to respond realistically. The latest version costs 
$1,200 11 and has replaced 100 dogs per year in veterinary classes at the New 
York school. 12 
(4) Computer Simulations . . . 
Some learning exercises can be conducted enurely �n compu�ers, �1thout h
ve
animals or even mannequins. Computer programs can sunu�ate dis_secuons, m
etabolic
functions, drug responses, and so on. Th_e re�lism ?f these _ slffi�lau
ons can _ �e 
increased by use of sophisticated interactive videodiscs, which display telev1S1o
n-
quality images on computer monitors. . 
Dr. J. Walker of the University of Texas uses �ompute!s to s1IDulate . 
physiological responses for medical stud;nts. �wo mexpensive c_ompu�ers
 �ubstitute
for experiments that demonstrate a dog s cardiovascular regulauon, di�esttve
 �ystem,
and drug responses. A recent article entitled The Electronic Guinea Ptg desc
nbes two
specific examples: 
During the cardiovascular experiment . . .  one computer screen dis�la�s a 
chart chat tracks blood pressure, heart rate, cardiac output, and �imtlar 
information, updated every three seconds; the other scre�n provides a 
continuous reading of the most vital data. If a st1:1dent wished to �ee the 
effects of the drug epinephrine - a standard medical scho_ol expe�imen� 
- he presses a key marked E. Immediately the screen registers a Jump m
blood pressure and heart rate. 
Another standard experiment involves slit_ting open _a dog's thro�t and . pinching off the arteries. A student can simulate this o� �alker s machme 
by pressing the O key: immediately the blood p
1�
essure mdicators nse, the 
cardiac output drops, and some lucky dog lives. 
A wide variety of such computer simulations is now available. 14 
(5) Other Procedures or Syste�� . . . . 
Other alternatives to tradmonal educational uses _of ammals u�clude replacmg 
dogs with videotapes to demonstrate the effects of poisons to vetermary students; 
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having two or more anatomy students dissect the same specimen or use prosections as 
demonstrations; and stipulating that adequately trained supervisors oversee students 
working on live animals. Finally, the potential for the use of neomorts in medical 
education should not be overlooked. 
Discussion 
Educators can have a profound effect on the replacement, reduction, and refinem�nt of educational uses of animals. In order to develop and implement alternanve�, educators need _the proper motivation, the support of their colleagues,and financial and academic mcentives. 
Scientists recognize the importance of academic incentives in developing educational alternatives, as this observation on development of computer-basedsimulators indicates: 
In the long run, the most serious problem to developing these simulators 
may :well_ be t�e lack of professional academic rewards for faculty members 
workmg_ m this area. Promotion, tenure, and salary increments are awarded
predommantl y for productivity in the research laboratory, not for efforts to 
develop innovative teaching techniques and materials. With essentially no 
external grant support for computer-based education activities and with few 
ref�reed high-quality journals in  which to publish, two of the measures by 
which !ewards are apportioned are not available to developers of novel 
educational software. This is a particular problem for junior faculty 
membe�s, who often must devote their major efforts to climbing the 
academic ladder. Computer-based education seemingly fails to meet the 
perception of an academically valid and credible enterprise.15 
A�though lack of £'.uncling may impede the development of alternatives in some 
cases, It may actually dictate the adoption of non-animal methods in others. For 
example, the ex-'?ense of procuring and housing dogs in medical schools may force 
these schools to lffiplement computer programs instead. 
Mo_ney, therefore_, is not all that's needed to foster widespread application of the alternatives approach m education. Concerned instructors educational 
administrators, funding agencies, students, and parents �ust be involved as well. 
. B!-1t no aJ?OUnt of effort will succeed unless the existing alternatives have merits 
�n th�u own nght. Does each alternative get the job done as well as or better than 
Its ammal-related counterpart? If not, is each alternative still adequate? Educators 
should clearly spell out the goals of their animal projects and determine whether or 
not alternatives meet those goals. 
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General Discussion 
PROGRESS IN IMPLEMENTING the alternatives approach has been encouraging, 
especially in light of the modest investment of money and effort. In to�city testing, 
the first generation of alternative screening tests i_s being develop�d, val1date1, 
and implemented. In biomedical research, invesngators ar� applymg alte!nanve 
techniques to answer questions in diverse fields. In ed�cat1on, tech�olog1cal 
innovation is yielding new alu:rnatives, such as robot-like mannequms and 
computer simulators. . . 
Much of this progress has occurred withi? the !ast ten y�ars, _as the �nlffial-:-nghts movement has infused the search for alternatives with an ethical lffiperative. Pnor to 
this, alternatives were pursued primarily for economic, public health: and scientific reasons but rarely as a reflection of a sense of moral duty or compassion. Even today, 
when specific alternatives are introduced to the scientific community i? research 
reports, concern for animals is not necessarily cited as a �eason for theu de�elopment 
or possible implementation. Nevertheless, the introduction of new alternatives, for 
whatever reason, is still good news. . The most exciting alternatives in the areas of research and testing are _based on 
the development of techniques such as tissue cult�e and co1;Ilputer 1:Ilodehng. _Such 
breakthroughs in technique have been extremely lffiportant m the history of sc�ence, 
as Rowan' has emphasized. Technical innovations are used to answer old questions 
and address new ones. A historical example is the application of tissue culture to the 
prevention of polio. The developmen� of a J?olio va�cine r�quir�d that large amounts 
of polio virus be readily available. This was impractical usmg mice an� monkeys, 
which were used extensively in polio research. Enders and coworkers d1�covered that 
the virus could be cultivated in vitro. This paved the way for Salk, Sabm, and others
to develop effective vaccines. A testament to the importance of the tiss_ue-culture
work in combating polio is that Enders and coworkers, not Salk or Sahm, were 
awarded the Nobel Prize for their polio research! 
Some new techniques are not alternatives i? themselves _ b_u� �an, noneth�less, 
decrease reliance on laboratory animals by creatmg new poss1bd1t1es for_ stud�mg 
humans without recourse to questionable animal models. An example 1s posmon 
emission tomography, discussed earlier in relation to human studies of 
Parkinson's disease. 
Techniques such as positron emission tomography, which decrease reliance on 
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a.i:iimal �odels by facilitat�ng the direct study of humans, are sorely needed in 
b1�medical research. Consider the remarks of Stephen Suomi, himself an advocate of 
animal models: 
The primary rationale for creating most animal models lies not so much in 
any obvious and impressive strengths of such models as it lies in the 
problems inherent in conducting research with humans as subjects. 2 
The primary pro_blem in conducting research on humans is avoiding undue risk or 
harm to the subJects. Consequently, new, powerful techniques that are relatively 
harmless should be eagerly embraced by animal modelers. 
Biomedical research is not the only area of laboratory animal use that has 
�enefited from the application of �ew techniques. A�ternatiye techniques, especially 
tissu�-c�lture and c_oI?-pute_r model�ng, are transformmg toxicology from an empirical 
exercise mto a predic�ive science._ Tissue-culture techniques can not only determine 
whether or not chemicals are toxic but also uncover how toxic chemicals exert their 
effects. Mo�e!ing can help identify the structural features of chemicals that are likely 
to cause toxicity. �urrent method_s treat each new chemical as a complete unknown 
and use whole ammals to determme whether or not a substance is toxic. 
The need for a transformat�on in toxicology was forcefully underscored by Nobel 
Laureate Joshua Lederberg, president of Rockefeller University: 
I think the testin� of substances could be greatly improved above all by 
better unders tandmg of the mechanisms by which these substances work. 
The o?e or two o� thre� hundred millions of dollars a year that we're now 
SJ?endmg on routme �mmal _tes�s are almost all worthless from the point of 
view of standard-settmg. It ts stmply not possible with all the animals in 
the world to _go through new chemicals in the blind way that we have at 
the present ttme, and reach credible conclusions about the hazards to 
human health.3 
To a substantial degree, our continued need for animals in testing is a function 
of our ignorance rather than our knowledge.4 In 1972, Nobel Laureate Sir Peter 
Medawar predicted that the use of laboratory animals on its then-current scale would 
dec�ease � biomed�cal knowledge increased. This should hold especially for toxicity 
testmg, given that its goals and methods are much more limited than those 
pertaining to research. 
Toxicity_ testing do�s compri_se a diverse array of tests. The replacement of all ofthese tests wtth alternative techmques will take a long time. In the meantime 
toxicologists s�10uld expl?it existing alternatives to the fullest extent. For ex�ple, if 
a co�prehensive evaluation of a new chemical requires both alternative tests and 
�.ra1��ional tests, t�e former should be conducted first; in this manner, chemicals thatfatl the alternatives tests need not be tested further on animals. 
Another w�y of reducing animal use in toxicity testing is to make results of 
these tests public. Many manufacturers of drugs, cosmetics, pesticides, and other 
compounds make extensive use of animals not only in toxicity testing but also in 
product development. The_ results of these investigations are sometimes regarded as 
trade secrets; thus, com�etu:�g companies may be inadvertently investigating the 
same co�poun�s, resulung m _a was�e o[ animals. Although competition among 
companies requues that t�ese �nvest�gattons be kept confidential to some degree,
such secrecy exacts a t?II m �imal ltfe and suffering. A compromise solution would 
be to requue compames to divulge the results of their investigations after a 
specified time.) 
Some comp�nies are taking steps to avoid unintentional repetition of toxicity 
tests .. Th� Chemical Industry Institute of Toxicology, for example, earmarks contnbutions from member companies for toxicological testing and distributes the 
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We have seen that poor and inhumane animal tests persist despite their faults. 
As Sharpe noted, "we cannot delegate our responsibilities onto other animals, who 
only reward us with illusions of safety. "7 The remedy for this sorry state of affairs in 
toxicity testing is not only better tests, especially alternative tests, but also the 
realization that the proper measure of man is man. The U nited States should 
consider adopting a post-marketing surveillance scheme patterned after the one used 
in Britain. Early detection of problems with new products in actual use should be an 
essential component of safety programs. This was recommended by a 1977 European 
convention on drug monitoring. The scientists in attendance concluded, in part: 
Only by the careful study of medicines in every day use can greatest 
benefits be obtained from their administration, the untoward rare potential 
disaster recognised at the earliest possible moment, and the ill effec ts 
minimised. Absolute safety is unattainable and its pursuit, regardless of 
other considerations, is achieving more harm than good [emphasis added].8 
Future progress on alternatives will depend, in part, on the extent to which the 
alternatives approach is embraced by biomedical scientists. While a few of these 
scientists view the approach favorably, the response of others has been lukewarm.9 
Researchers seldom target their work toward alternatives as ends in themselves. Some 
dismiss the approach altogether. 10• 11 Recent progress on alternatives suggests that 
these naysayers are fighting a losing battle. 
Several factors probably contribute to the scientific community's resistance to the 
alternatives approach. First, alternatives tend to be viewed in the narrow sense of 
replacements. Because replacements for some types of laboratory animal procedures 
will take many years to develop, this narrow view of alternatives engenders 
unnecessary pessimism. Adoption of the broader definition of alternatives as 
reductions and refinements as well as replacements should make the alternatives 
approach seem less quixotic. 
A second reason for scientists' resistance to alternatives may be that alternatives 
are promoted by (among others) the opponents of animal research, namely, 
anti-vivisectionists. Animal researchers may not want to be seen as giving in to their 
opponents or they may view anti-vivisectionists as zealously promoting alternatives 
that are ineffective in order to save animals. 
A third and related reason is that advocates for alternatives may be viewed as 
irrational and anti-research. However, the target of these advocates is not research in 
· general, but animal research. G iven the extent to which groups advocating
alternatives are funding research on alternatives, the anti-research charge seems to be
a smoke screen. 
Fourth, researchers who were trained to use animals may be hesitant to learn
new techniques. 
Perhaps the most cynical suggestion for the resistance to alternatives is that
alternatives pose a threat to the multi-billion-dollar industry of animal research. 
Thousands of people make a living from animal research. Scientists do so by 
conducting the research; veterinarians by administering to research animals; dealers
by selling animals; and manufacturers by supplying cages, food, antibiotics, etc. 
Research institutions also profit by receiving a hefty percentage of the money
awarded to their individual researchers. Some of these people or institutions 
undoubtedly would rather maintain the status quo than make the adjustment to an
alternatives-based research industry. 
Some money is given specifically for alternatives research. Though the amount is
small compared to funding for animal research, it may lure some animal researchers 
into alternatives. T.D. Overcast and B.D. Sales claim that some animal researchers 
are pursuing alternatives for another reason, namely, to protect themselves from the 
impact of future regulations on animal research. 12 However, this claim may have 
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been made more for its alarmist effect on regulators and its portrayal of animal 
researchers as beleaguered than for its reflection of a realistic trend. 
Of cou�se, it would be foolish to suggest that all biomedical scientists oppose 
the alternatives_ approach and all have questionable motives, even those who 
pursue alternat1ves. 
Whatever the motivations and beliefs of researchers the case for alternatives 
�ust �lti1!1ately b� judged on its own merits. There is a 'surprising amount ofh1st�ncal mform�t10� on which to base this judgment. In the following analysis, 
co�s1der alternatives m the narrow sense of techniques that avoid the use of intact 
�mmals altogether. A ctually, this is too narrow a definition because we want to 
mclude the use of "less sentient organisms" (invertebrates, microorganisms, plants, 
�nd ve_rtebrate embryos) as an alternative technique. And, of course, we are also 
mclu_dmg hu�an and in vitro studies, mathematical modeling, and 
phys1cal-chem1cal techniques. 
. Most of the�e techniques have existed for decades, although they have not been d1scuss_ed much m the c�>ntext of alternatives until the last ten years or so. 
So�et1mes, these techmques were used in projects that could have been conducted 
on mt�ct vertebrate animals; today, we' cl categorize these as alternative projects. In 
other !�s_tances, "alternative" techniques were used in projects that were beyond the 
capabdmes of vertebrate studies. 
. Nobel Prize awards in medicine or physiology can be used as an index of the 
Importance of alternative techniques in the history of biomedical research. These 
award� ar� generally believed to recognize research "of the highest calibre, the most 
end�rmg mfluence, and the most importance to biomedical science" according to the 
National A cademy of Sciences (NA S). 13 
A wards that we_re made fo� rese�rch whose success depended wholly or primarily 
on alternative techmqu�s wer� 1d�nt1fied. The remaining awards were for projects 
that were successful owmg prtmardy to in vivo studies of vertebrates labeled 
non-alternative techniques. Sufficient information was available to c'lassify all but 
two awards. AI_though most of the other seventy-four awards were readily classified, 
some proved difficult. These _w_ere generally assigned to the non-alternative category. 
Wh�n th� same award "'.'as dlVlded among two or more projects, the award was 
class1�ed �n the alternauve categ?ry as long as at least one project depended wholly 
or pnmardy on alternative techmques. 
About fifty (or two-thirds) of the Nobel Prizes were awarded to projects using 
�lternattve techniques (see A ppendix A ). This finding clearly documents the 
1mportanc� of t�ese techniques in the history of biomedicine. The techniques 
advocated m this report have been used to conduct first-rate biomedical research and 
can contmue to do so. 
Those projects that used alternative techniques were further classified as to 
whether the projects themselves can be considered alternatives to research on whole 
�erteb_rates or "."hether the projects investigated topics that could not have been 
mvesugated usmg "."hole v�rtebrates. Although there were several equivocal cases, the 
fifty aw_ards for proJects usmg alternative techniques fell about equally in both 
categones (twe�ty-four and twenty-six, respectively). 
The �echmques advocated in this report have been the cornerstone of some of 
the t�ent1eth century's most significant biomedical research. In some cases, they have 
subsmu_ted for the use of vertebrates; in other cases, they have added to our 
b1omed1cal kn?wled�e in ways that were not feasible using vertebrates. 
T
_w
o cons�derat1ons are important in interpreting the results of the Nobel 
analysis : One 1s that most of the award-winning projects were conducted before the alternat1ve� appr?ac� was �rst articulated ( 1959). This increases expectations of what 
�an be achieved if b10med1cal researchers actively pursue alternatives as ends 
m themselves. 
The sec�nd consi?erati�n is that more awards would have gone to projects that 
used alternat1ve techmques if not for the traditional emphasis on in vivo vertebrate 
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studies in biomedical research. For example, many animal researchers were skeptical 
of tissue-culture systems in the early days of this technique's existence. According to 
NAS, if not for this skepticism, tissue culture "might have been used to discover 
many of the vitamins, amino acids, and hormones."
14 Tissue culture could have been 
used to discover the hormone insulin, for instance. Even human studies could have 
yielded this discovery. Yet the researchers who discovered insulin used traditional in 
vivo methods, with dogs. They were awarded the Nobel Prize in 1923. This 
by-product of tradition is often regarded as a triumph of animal research, yet other 
techniques could have done the job. 
Twentieth century Nobel Prizes in medicine or physiology were analyzed from a 
somewhat different perspective by NAS, which focused on the types of organisms 
used in the award-winning research, instead of on techniques. The results were 
compared to funding patterns of NIH to assess whether funds were allocated among 
types of organisms according to their representation in award-winning research 
(which presumably is some indication of the relative value of these organisms 
in biomedicine). 
NAS concluded that research on mammals was being overfunded in relation to 
its representation in the Nobel awards and in other outstanding research: 
Considering the great strides in our understanding of biology and medicine 
that have resulted from the study of microorganisms, invertebrates, and 
lower vertebrates, the proportion of NIH resources that supports research in 
this area may be small in comparison to the resources dedicated to research 
with mammals. 1) 
This suggested misapplication of funds may result from what was described 
earlier as the high fidelity fallacy- that mammals are of exceptionally high fidelity as 
models of humans and therefore should be used as often as possible. NAS 
recommended resisting this perspective: 
Proposals for the study of invertebrates, lower vertebrates, microorganisms, 
cell- and tissue-culture systems, or mathematical approaches should be 
regarded as having the same potential relevance to biomedical research as 
proposals for work on systems that are phylogenetically more closely related 
to humans. Support should be given to good research without taxonomic or 
phylogenetic bias on the part of the sponsor and should include 
comparative and phylogenetic studies. 16 
NAS's recommendation is directed at NIH funding patterns such as the one 
depicted in Figure 1. The figure displays information for 1983, the most recent year 
for which information is available. Information from previous years (1980-1982) 
shows similar trends. Note that research on vertebrate animals, especially mammals, 
was the highest funded category. It exceeded the combined funding for research 
using in vitro techniques, mathematical modeling, and less sentient organisms 
(invertebrates, microorganisms, and plants). Funding for research on nonhuman 
mammals alone exceeded funding for human research, despite the fact that the 
mission of NIH is to protect human health. 
Funding decisions are influenced to a certain extent by the interests and 
perspectives of the scientific community. Hence, alternatives research undoubtedly 
would be a higher priority if scientists supported the alternatives approach. In issues 
that involve the use of animals in research, such as alternatives, scientists are often 
portrayed as being engaged in polarized battles with anti-vivisectionists. In a sense, 
we are all anti-vivisectionists because none of us wants animals to have to suffer or 
die in laboratories. The alternatives approach can provide a common ground for both 
researchers and animal advocates to demonstrate their humane concern. This view is 
reflected in the policy of The Humane Society of the United States on the use of 
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FIGURE 1 
NIH Funding, 19831 









Vertebrates (34% )  





1. Distribution_ of support from the National Institutes of Health (NIH) for research on various organisms �unng 1983. ��g_ures are for _excramu�al research (i.e., research not conducted at NIH) only. Miscellaneous mcludes proJects on mvertebrates in combination with various other organisms. 
SOURCE: Adapted f�om Table 4-3 in National Academy of Sciences, Models for Biomedical Rese(lrr;h (Washington D.C.: Nauonal Academy Press, 1985).
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laboratory animals (see Appendix B). 
Enthusiastic support for the alternatives approach, not only by researchers and 
animal-rights advocates but also by funding agencies, regulatory agencies, educators, 
and the general public, will hasten the day when laboratory animals are spared from 
their regrettable plight. 
The alternatives approach is part of a more inclusive approach toward animal 
research that is characterized by concern for animals. This humane concern can be 
expressed in various ways in addition to seeking replacement, reduction, and 
refinement. For example, researchers contemplating the use of animals should 
determine, first, whether their topic is worth investigating and, second, whether 
their research would involve unnecessary duplication. Such duplication can be 
reduced by searching through computerized bibliographies of published research 
reports and by determining whether relevant research published in foreign languages 
has been translated. The John Crerar library at the U niversity of Chicago is a 
clearinghouse for such translations. Third, researchers should determine whether the 
chosen animal species is the best ( or at least an adequate) subject of study. Research 
conducted on poor or invalid "animal models" is a waste of animals and effort. 
Albert Schweitzer was a prominent exponent of this perspective. He wrote: 
Those who carry out scientific experiments with animals, in order to apply 
the knowledge gained to the alleviation of human ills, should never 
reassure themselves with the generality that their cruel acts serve a 
useful purpose. 
In each individual case they must ask themselves whether there is a real 
necessity for imposing such a sacrifice upon a living creature. They must try 
to reduce suffering insofar as they are able . 17 
A humane approach to research goes beyond asking questions about specific 
projects. It calls for a reappraisal of the entire biomedical research paradigm, which 
emphasizes the development of treatments for people who are already sick. The 
application of this paradigm has exacted a heavy toll in animal suffering and death. 
Many people have cogently argued that this paradigm is misguided even from the 
point of view of human health. 18 Human health would be better served if prevention 
were emphasized over treatment. A biomedical research program that emphasized 
prevention would shift research away from animal studies and direct it more toward 
screening programs and alternative techniques, especially epidemiological and clinical 
studies on humans. 
The case for prevention over treatment was recently made by John Cairns of 
Harvard U niversity's School of Public Health19 in a discussion of cancer research. 
About one hundred different kinds of human cancer are recognized. Because these 
cancers have their own characteristics, each should be considered as if it were a 
separate disease. U nfortunately, fewer than fifty percent of cancer patients can be 
cured by surgery. Supplementary treatments involve administration of hormones, 
radiation, and chemotherapy. The success rate of these supplementary treatments has 
been disappointing; they avert only about two to three percent of the 400,000 deaths 
from cancer each year in the U .S., and they can have serious, sometimes lethal, side 
effects. Cancer specialist Dr. H. Bush notes that some treatments are so physically 
and psychologically degrading that some patients wonder whether the treatment is 
more disabling than the disease. 20 Although some cancers can be effectively treated, 
these are not the major forms of cancer. 
Cairns contrasted the disappointments with our national cancer policy, which 
emphasizes treatment, with a potential policy that emphasizes screening and 
prevention. He wrote: 
Thanks to the cigarette, the U . S. now suffers a completely unnecessary 
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additional 100,000 deaths per year from lung cancer. These numbers dwarf 
the 5,�00 to 10,000 lives that are being saved by chemotherapy. Some 
countnes have banned all tobacco advertising, and this has had an almost 
instant effect on tobacco sales. The failure of the U.S. Government to take 
such a step far outweighs all the advances made in the treatment of cancer 
since the advent of modern surgery. 
Cairns also turned to the history of modern medicine to support his case for a 
prevention-based cancer policy: 
None of the important causes of death has been primarily controlled by 
treatment. The death rates from malaria, cholera, typhus, tuberculosis, 
scurvy, pellagra, and the other scourges of the past have dwindled in the 
U.S. _mainly because humankind has learned how to prevent these diseases, 
not sunply because they can be treated. There are many grounds for 
believing that when any major disease is tackled on a national scale the 
chief effort should be to prevent its occurrence. To put most of the 'effort 
into treatment is to deny all precedent . 
T�e so-called war �n. cancer is just one example of limited gains resulting fromanunal research. Mtlhons of dollars have been spent searching for elusive cures to 
various other diseases, while suppon for diagnostic programs and preventive measures 
pales in comparison. Humans as well as animals are the losers. 
While defenders of animal research are quick to point out the successes of 
animal research, they fail to add that the advancement of medicine and human 
health has been hindered by an overemphasis on this form of research. In addition 
to c�ncer researc_h , examples include research on cocaine abuse,21 depression,22•23 and 
cardiovascular diseases. 24 
Our i�ated hopes [�r animal-based treatments are undoubtedly fueled by 
rese��hers self-aggran�mng pronouncements and the resulting media hype. As 
physman Bush noted with respect to cancer research, "Cures seem to happen more in 
press releases than in patients."2) Dr. P .  Goldhaber, the dean at Harvard's School of 
Dental Medicine, argued that researchers are "boasting prematurely about the 
advances and triumphs" of their work and are "extrapolating prematurely 
from . . .  an�al studies to humans. "26 He cited the fields of dentistry, cancer and 
tuberculosis research to support his conclusion . 
An emphasis on cure detracts not only from prevention but also from the 
physical and psychological care of the sick. Bush wrote: 
As many cancer clinicians have found, a diagnosis of cancer can so 
demoralize a patient that the debilitating effects are far worse than the 
early physical effects of the disease . . . .  
It is time that more of the research dollars now devoted to cure be diverted 
to finding new and more humane ways of caring that will make a can�er 
patient's �emaining years happier, more comfortable, and more productive. 
My expenence suggests that in the patient's eyes good care aimed at 
improving the quality of life may be just as imponant as cure. 27 
There are signs that our national cancer policy is beginning to reflect the 
importance of prevention .28 The National Cancer Institute is financing the 
establishment ?f "cancer prevention research units" around the country to discover 
c�cer-prev�ntmg strateties, including dietary changes . Instead of using laboratory 
an11I.1als, t�is research will test "likely cancer preventives in the most persuasive way 
possible- m the real world, over periods of years , on thousands of healthy 
human beings ."29 
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A reorientation of research toward prevention need not entail a total 
abandonment of research aimed at treatment. However, treatment-based research 
should take advantage of new applications of alternative techniques in a wide variety 
of areas, including cancer30 and AIDS. 
The paradigm shift from treatment to prevention can be translated into our 
everyday lives . On the basis of numerous human studies, physician J. Scharffenberg 
concluded that personal health and salvation from disease are largely a matter of 
personal choice. He described a life-style that promotes health and dramatically 
reduces the risk of disease. It includes, among other things , 
a good diet of fruits, whole grains, nuts, and vegetables while avoiding the 
meat and high animal fat products and eggs, adequate sleep, good exercise 
in the open air, abstinence from harmful things such as tobacco, alcohol, 
coffee, tea, and other drugs, drinking plenty of water, moderation in all 
things including the amount of food eaten . . . .  31 
Taking greater personal responsibility for our own health would lessen our 
reliance on animal-based treatments. In the event that we become sick, we should 
think twice before taking drugs that were developed or tested on animals. Are 
treatments available that are not animal-based? Will rest and relaxation be sufficient 
for recovery? 
In a similar vein, we should keep laboratory animals in mind when shopping. 
First, we should buy products whose development and testing did not involve 
animals. A list of companies that sell "cruelty-free" cosmetics and toiletries is 
available from The Humane Society of the United States. Second, we should avoid 
buying household products that are "new and improved," as these modifications 
probably necessitated further animal testing. 
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Conclusions 
RECENT PROGRESS in the development and implementation of alternatives is 
encouraging, especially given the relatively small investment of money and effort. 
Technical advances are already being translated into tangible results, not only in 
terms of animal welfare, but also in public health and cost savings. The public's 
concern for animals is partly responsible for this progress. 
The application of the alternatives approach is still far from the ultimate 
goal of eliminating the use of laboratory animals. What is needed is a more 
concerted effort among researchers, toxicologists, educators, funding agencies, and 
regulatory agencies. 
Whether or not such an effort is made will depend in large part on public 
enthusiasm. As a fust step, people should familiarize themselves with the alternatives 
approach. This will enable them to recognize wild exaggerations made by 
animal-research defenders; for example, that biomedical research would collapse 
without the traditional use of animals or that the only alternative to using animals is 
to use ourselves. 
Researchers probably would take alternatives more seriously if more people 
became knowledgeable on the topic. Researchers and laypersons eventually may share 
the goal of replacing animals in laboratories. If this goal is met, our mental image of 
biomedical research as an animal huddled in a cage will be replaced by more 
heartening images. 
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Nobel Prizes in Medicine or Physiology A warded for Research Whose Success 
Depended Primarily or Wholly on Alternative Techniques. 
YEAR WINNER TECHNIQUE1 TOPIC 
1902 R. Ross LSO Discovered insect vector of 
malaria and other aspects of this 
disease 
1903 N. Finsen IV Treatment of diseases, especially 
lupus melgaries with concentrated 
light radiation 
1907 C. Laveran H Role of protozoa in causing 
diseases 
1908 E.  Metchnikoff LSO, IV Immunity 
1909 T .  Kocher H Physiology, pathology, and 
surgery of the thyroid gland 
1910 A. Kosse! IV Protein chemistry of cells, 
including nucleic substances 
1911 A .  Gullstrand H, MM Dioptrics of the eye 
1914 R. Barany H Physiology and pathology of the 
vestibular apparatus 
1915-1918, 1921, 1925: No Prizes Awarded 
1927 J. Wagner-Jauregg H Malaria inoculation in treatment 
of dementia paralytica 
1928 C. Nicolle H Work on typhus 
1930 K. Landsteiner IV Discovery of the human blood 
groups 
1931 0. Warburg IV Nature and mode of action of the 
respiratory enzyme in yeast 
1933 T. Morgan LSO or IV Role of the chromosome in 
heredity (fruit flies) 
1935 H . Spemann LSO Organizer effect in amphibian 
embryonic development 
1937 A. von Szent-Gyorgyi IV Biological combustion process, 
with special reference to vitamin 
C and the catalysis of fumaric acid 
1940-1942: No Prizes Awarded 
1944 J .  Erlanger IV Differentiated functions of single 
H. Gasser nerve fibers 
1945 A .  Fleming IV Penicillin and its curative effect 
E. Chain on various infectious diseases 
H. Florey
1946 H. Muller LSO Production of mutations by X ray 
1948 P. Muller LSO Efficiency of DDT as a contact 
poison against several arthropods 
1949 E. Moniz2 H Therapeutic value of a 
psycho-surgical procedure in 
certain psychoses 
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YEAR WINNER TECHNIQUE' TOPIC YEAR WINNER TECHNIQUE' TOPIC 
1951 M. Theiler IV Vaccine against yellow fever 1972 R. Poner IV Chemical structure of antibodies 
1953 H. Krebs IV Citric acid cycle and coenzyme A G. Edelman IV 
F. Lipmann and its role in intermediary 1973 K. von Frisch Mi Organization and elicitation of 
metabolism K. Lorenz Mi individual and social behavior 
1954 J. Enders IV Cultivation of poliomyelitis N. Tinbergen Mi patterns 
F. Robbins viruses in tissue culture 1974 A. Claude IV Structural and functional 
T. Weller G. Palade IV organization of the cell 
1955 H. Theorell IV Nature and mode of action of C. de Duve IV 
oxidizing enzymes 1975 R. Dulbecco IV Interaction between tumor viruses 
1956 A. Cournand H Heart catheterization and D . Baltimore IV and the genetic material of cells 
W. Forssmann pathological changes in the H. Temin IV 
D. Richards circulatory system 1976 B. Blumberg2 H New mechanism for the origin 
1958 G. Beadle LSO Genes regulate chemical processes and dissemination of infectious 
E. Tatum (bread mold) disease 
J. Lederberg LSO Genetic recombination and the 1977 R. Yalow IV Development of radioimmuno-
organization of the genetic assay and the principles 
apparatus of bacteria underlying it 
1959 S. Ochoa IV Mechanisms of the biological R. Guillemin Mi Hypothalamic hormones 
A. Kornberg synthesis of RNA and DNA A. Schally 
1962 F. Crick IV Molecular structure of nucleic 1978 W. Arber LSO/IV Discovery and application of 
J. Watson acids and its significance for the H. Smith LSO/IV restriction enzymes 
M. Wilkins transfer of information in living D . Nathans LSO/IV 
material 1979 A. Cormack MM, H Development of the X ray 
1963 J. Eccles IV Ionic involvement in the G. Hounsfield MM, H diagnostic technique, computer-
A. Hodgkin excitation and inhibition of nerve assisted tomography 
A. Huxley cell membranes 1981 R. Sperry2 H Functions of the cerebral 
1964 K. Bloch LSO, IV Mechanism and regulation of hemispheres 
F. Lynen cholesterol and fatty acid 1982 S. Bergstrom IV, PC Biochemistry and physiology 
metabolism B . Samuelsson IV, H of prostaglandins 
1965 F. Jacob LSO Genes that control activity of J. Vane IV 
A . Lwoff other genes 1983 B. McClintock LSO Discovery of mobile genetic 
J. Monod elements (in corn) 
1966 C. Huggins2 H Hormonal treatment for cancer of 1984 C. Milstein IV Development of a technique for 
prostate and breast G. Kohler3 monoclonal antibody formation 
1967 G. Wald2 IV Chemical and physiological visual 1985 M. Brown IV, H Cholesterol biochemistry and 
K. Hartline LSO, H process in the eye J. Goldstein familial hypercholesterolemia 
1968 M. Nirenberg IV Interpretation of the genetic code 
R. Holley IV and its function in protein 
H. Khorana IV synthesis 
1969 M. Delbruck LSO/IV Replication mechanism and IH = Human Studies, IV = In Vitro Studies, MM = Mathematical Modeling, PC = Physicochemical 
A. Hershey LSO/IV genetic structure of bacterial Techniques, LSO = Studies of Less Sentient Organisms (Vertebrate Embryos, Invertebrates, 
S. Luria LSO/IV viruses Microorganisms , and Plants), and Mi = Miscellaneous. 
1970 B. Katz2 IV Transmitters in nerve terminals 
2Award shared with researcher(s) who used non-alternative methods. 
and the mechanism of their lAward shared with N. Jerne for his theoretical conuibution. 
storage, release, and activation SOURCES: 
1971 E. Sutherland, Jr. IV Mechanisms of the action of 
Sourkes, T.L. Nobel Pn'ze Winners in Medicine and Physiology, 1901-1965 (New York:
Abelard-Schuman, 1966). 
hormones Science. 1966-1985. Various articles on Nobel Prize winners. 
Garfield, E. "The 1984 Nobel Prize in Medicine Is Awarded to Niels K. Jerne, Cesar Milstein, and 
Georges J.F. Kohler for Their Conuibutions to Immunology," Cu"ent Contents ( 1 1  November 1985).
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Animals in Biomedical Research and Testing, from Statement of Policy, 
The Humane Society of the United States ( 1984). 
The Humane Society of the United States recognizes that benefit for both 
animals and mankind has been achieved through some scientific research and testing 
on animals, but that the advancement of medicine and human health has also been 
hindered by an overemphasis on such animal research. It recognizes that uses of 
animals in biomedical research, safety testing, and other programs are many and 
varied, and that this research and testing is not likely to end in the 
immediate future. 
While some of the animals used in research and testing are subjected to 
procedures that result in only momentary discomfort, The HSUS believes that 
millions of laboratory animals do suffer severely and needlessly in painful 
experiments, resulting from exposure to noxious substances and pathogenic 
organisms, or from cruelty, carelessness, ignorance, and indifference. The HSUS also 
contends that toxicity testing on live animals, as now required by government 
agencies to test the safety of serums, drugs, cosmetics, and other chemicals, is often 
unreliable, inaccurate, and unnecessary and should be replaced as soon as possible by 
new methods not involving animal suffering. Existing measures intended to ensure 
humane treatment, including the Animal Welfare Act and its enforcement, have 
proven inadequate. The Animal Welfare Act should be strictly enforced. Coverage 
should be expanded to include all vertebrates used, protect animals undergoing the 
actual research and experimental process, and require prohibition of specific painful 
invasive procedures. 
The HSUS believes that scientists and facilities using experimental animals 
should be held strictly accountable for their care and use and should keep animals in 
a manner fulfilling both physical and behavioral needs. Experiments should be 
rigorously planned, with proper statistical design, so as to minimize the number of 
animals necessary to be used to achieve reliable results and, through the 
administration of anesthesia and analgesics and other appropriate medication and 
veterinary care required, to preclude animal suffering. The HSUS believes that 
government agencies and relevant professional organizations should encourage and 
actively support efforts to eliminate animal suffering in the laboratory. 
Therefore, The HSUS strongly advocates the development and application of 
alternative methods of research and testing, which could reduce the number of 
animals required, refine existing techniques and procedures so as to minimize the 
level of stress endured by an animal, and replace the use of laboratory animals. 
Refinement and reduction are interim steps toward the ultimate goal of complete 
replacement of animals in biomedical research and product testing. 
Therefore, it is the policy of The Humane Society of the United States to use 
every means in its power to reduce and end the suffering of animals in biomedical 
research and testing laboratories by advocating the attitudes and approaches set forth 
in this statement. 
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Acute toxicity: Toxic effects produced by a single dose of a compound. Dose is often 
large relative to the body weight of the animal. The test usually is limited to one to 
two weeks in duration. 
Analgesic: Substance used to induce insensitivity to pain without loss 
of consciousness. 
Anatomy: The structure of an organism. 
Animal model: A particular type of animal used as a surrogate for humans in a 
research project. The animal is defined by its species and perhaps additional features, 
such as genetic uniformity. 
Assay: A procedure or system used to determine the potency or concentration of 
a compound. 
Bioassay: A procedure or system used to determine the potency or concentration of a 
compound by its effect upon animals, isolated tissues, or microorganisms, as 
compared with a standard preparation. 
Biological: Biologically active substances such as hormones, antibodies, vaccines, 
and antiserum. 
Biopsy: A specimen of tissue obtained from living patients for diagnostic 
examination; or the process of removing this tissue. 
Carcinogen: Any agent that produces cancer. 
Carcinogenic: Causing cancer. 
Cardiopulmonary resuscitation: Restoration of breathing and heartbeat after 
apparent death. 
Chronic (long-term) : Multiple doses or continual exposure in. feed, water, or . atmosphere to determine safety thresholds and long-term toxic effects. Duration of
exposure can be two years or longer. 
Chorioallantoic membrane: A membrane found in the avian egg. 
Clinical: Relating to observations of a patient or the course of his or her symptoms; 
often used in contradistinction to experimental, as in experimental study of animals 
intentionally made sick. 
Conjunctiva: The membrane that lines the inner surface of the eyelids and connects 
to the forepart of the eyeball. 
Congenital: Existing at birth; referring to certain mental or physical traits or 
peculiarities, malformations, etc. 
Cornea: The transparent, front part of the eye that covers the iris and pupil. 
Dissection: The act of cutting apart the tissues of the body in the study of anatomy 
(or in a surgical operation). 
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Enzyme: A protein secreted by cells that acts as a catalyst to induce chemical changes 
in other substances. 
Epidemiology: The study of the prevalence and spread of disease in a community, 
especially infectious and epidemic diseases. 
Genetic: Referring to the hereditary (or genetic) material . 
Hormone: A chemical substance formed in one organ or part of the body and carried 
in the blood to another organ or part. Hormones can alter functional activity, and 
sometimes even the structure, of one or more organs. 
Immune system: The body's system that is involved in combating infectious diseases, 
rejecting foreign tissue, and inducing hypersensitivity (allergic reaction) to 
specific substances. 
Invertebrate: The taxonomic name for multi-cellular animals without backbones; for 
example, worms, crayfish , flies , and beetles. 
Invasive: Referring to procedures that involve penetrating the body, as in surgery. 
In Vitro: In a test tube or other laboratory container; referring to bodily tissue, cells, 
or cellular components studied in isolation. See in vivo.
In Vivo: In the living body; referring to processes studied in the intact organism , as 
opposed to in vitro.
Iris: The part of the eye that controls the amount of light hitting the lens; the iris is 
variously colored in different individuals . 
Median: The middle value in a set of measurements; an 1D50 value is the median 
lethal dose. 
Metabolism: The sum of the processes by which a particular substance is handled 
biochemically by the body . .  
Microsome: One of the small , spherical vesicles derived from a cell structure (the 
endoplasmic reticulum) during isolation of cell-free extracts . It does not exist as such 
in the undisrupted cell. 
Microsurgery: Surgical procedures performed under the magnification of special 
surgical microscopes. 
Mutagen: Any agent that induces mutations. 
Mutagenic: Causing mutation. 
Mutation: A change in the genetic material that is perpetuated in subsequent 
divisions of the cell in which it occurs . 
Neomort: The body of a recently deceased person. 
Nervous system: The body's system involved in transmitting nerve impulses from 
receptor organs, such as the eye, to the brain (or spinal cord), where they are 
interpreted; this may result in a response that consists of a nerve impulse being 
transmitted to an effector, such as the hand. 
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Ophthalmic: Relating to the eye. 
Pathological: Resulting from disease. 
Physiology : The study of the normal, vital processes of animals and plants, such 
as respiration. 
Postmortem: After death, referring to examinations of corpses. 
Replication: The act of repeating a process or observati?�;- in genetics, referring to the duplication of genetic material that precedes cell d1vts1on. 
Spinal reflex: An involuntary movement in response to stimulation to the body's 
surface and transmitted to the spinal cord. 
Statistics: A discipline that deals with techniques for designing research and for 
analyzing and drawing conclusions from the resulting data. 
Structure/activity relationship (SAR): A mathematical model that relates the 
structure of a series of chemicals to their activity, such as toxicity. 
Teratogen: Any agent that induces abnormal development,
particularly malformations. 
Teratogenic: Causing abnormal development. 
Toxicity: The state of being toxic or poisonous. 
Vertebrate: The taxonomic name for animals with backbones, namely, fishes, 
amphibians, reptiles, birds, and mammals. 
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